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The skin is composed of two major compartments, the dermis and epidermis. The 
epidermis forms a barrier to protect the body. The stratified epithelium has self-renewing 
capacity throughout life, and continuous turnover is mediated by stem cells in the basal 
layer. p63 is structurally and functionally related to p53.  In spite of their structural 
similarities, p63 is critical for the development and maintenance of stratified epithelial 
tissues, unlike p53. p63 is highly expressed in the epidermis and previously has been 
shown to play a critical role in the development and maintenance of the epidermis.  The 
study of p63 has been complicated due to the existence of multiple isoforms: those with 
a transactivation domain (TAp63) and those lacking this domain (ΔNp63). Mice lacking 
p63 cannot form skin, have craniofacial and skeletal defects and die within hours after 
birth. These defects are due to the ability of p63 to regulate multiple processes in skin 
development including epithelial stem cell proliferation, differentiation, and adherence 
programs. To determine the roles of these isoforms in skin development and 
maintenance, isoform specific p63 conditional knock out mice were generated by our 
lab. TAp63-/- mice age prematurely, develop blisters, and display wound-healing defects 
that result from hyperproliferation of dermal stem cells. That results in premature 
depletion of these cells, which are necessary for wound repair, that indicates TAp63 
plays a role in dermal/epidermal maintenance. To study the role of ΔNp63, I generated a 
ΔNp63-/- mouse and analyzed the skin by performing immunofluorescence for markers 
 vii 
of epithelial differentiation. The ΔNp63-/- mice developed a thin, disorganized epithelium 
but differentiation markers were expressed. Interestingly, the epidermis from ΔNp63-/- 
mice co-expressed K14 and K10 in the same cell suggesting defects in epidermal 
differentiation and stratification. This phenotype is reminiscent of the DGCR8fl/fl;K14Cre 
and Dicerfl/fl;K14Cre mice skin. Importantly, DGCR8-/- embryonic stem cells (ESCs) 
display a hyperproliferation defect by failure to silence pluripotency genes. Furthermore, 
I have observed that epidermal cells lacking ΔNp63 display a phenotype reminiscent of 
embryonic stem cells instead of keratinocytes. Thus, I hypothesize that genes involved in 
maintaining pluripotency, like Oct4, may be upregulated in the absence of ΔNp63.  To 
test this, q-RT PCR was performed for Oct4 mRNA with wild type and ΔNp63-/- 18.5dpc 
embryo skin. I found that the level of Oct4 was dramatically increased in the absence of 
ΔNp63-/-.  Based on these results, I hypothesized that ΔNp63 induces differentiation by 
silencing pluripotency regulators, Oct4, Sox2 and Nanog directly through the regulation 
of DGCR8. I found that DGCR8 restoration resulted in repression of Oct4, Sox2 and 
Nanog in ΔNp63-/- epidermal cells and rescue differentiation defects. Loss of ΔNp63 
resulted in pluripotency that caused defect in proper differentiation and stem cell like 
phenotype. This led me to culture the ΔNp63-/- epidermal cells in neuronal cell culture 
media in order to address whether restoration of DGCR8 can transform epidermal cells 
to neuronal cells. I found that DGCR8 restoration resulted in a change in cell fate. I also 
found that miR470 and miR145 play a role in the induction of pluripotency by 
repressing Oct4, Sox2 and Nanog. This indicates that ΔNp63 induces terminal 
differentiation through the regulation of DGCR8.  
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Chapter 1. Introduction 
 
1.1. Gene structure of p63, a p53 family member 
 p63, a p53 family member, contains three domains: a transactivation domain (TA), a 
DNA binding domain and an oligomerization domain. All three domains bear homology 
to p53 and transactivate common target genes (Yang et al., 1998) (Figure 1).  p63 is 
located on chromosome 3q27-29 in human and chromosome 16 in mouse.  The p63 gene 
uses two distinct promoters which results in multiple isoforms (TA contains a 
transactivation domain and ΔN lacks a conventional transactivation domain but has an 
alternative transactivation domain (proline repeat in 5’ upstream)) and has alternative 3’ 
end splicing variants that produce α,β and γ isoforms (Figure 1) (Yang et al., 1998). p63 
is highly expressed in the basal layer of epidermis and is differentially expressed in 
various tissues in an isoform dependent manner, while p53 is ubiquitously expressed.  
The progenitor and stem cell populations reside in the basal layer of the epidermis. 
Normal epithelial tissues such as skin, mammary glands, prostate, tongue and esophagus 
show high expression of p63 (Yang et al., 1998) and in these tissues, expression of p63 
is gradually lost by differentiation.  
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Figure 1. The schematic structure of p63 and its isoforms 
A. p63 has 15 exons and employs two independent promoters. 
B. p63 contains a transactivation (TA), a DNA binding and an oligomerization domain. 
These have much similarity to p53.   
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1.2. The general roles of TAp63 and ΔNp63 isoforms  
1.2.1. The roles of TAp63 isoforms  
 TAp63 isoforms transcribe p63 gene that structurally resembles p53 and 
functions as a transcription activator (Yang et al., 1998). Since it has structural similarity 
to p53, it is largely believed that p63 functions as a tumor suppressor. However, p63-/- 
mice show striking developmental defects that prompted study of the developmental 
roles of p63. Here I introduce the roles of TAp63 in advance of discussing the roles of 
ΔNp63 in embryonic development later in Chapter 1.  
p63 knock out mice were generated by two groups (Mills et al., 1999; Yang et 
al., 1999) and striking knock out phenotypes were observed with apparent 
developmental defects such as truncated limbs, cleft plate and immature skin (Figure 2) 
(Mills et al., 1999; Yang et al., 1999). Identified functions for p63 in the stratified 
epithelium include commitment to differentiation, the maintenance of cell junctions, and 
stem cell proliferation (Carroll et al., 2007; Carroll et al., 2006; Ihrie et al., 2005; Koster 
et al., 2007; Koster et al., 2004). Many of these functions are controlled by a numerous 
transcriptional networks of genes regulated by p63 (Vigano et al., 2006; Vigano and 
Mantovani, 2007; Yang et al., 2006). TAp63 isoforms act initially during early 
epidermal development, however TAp63 levels are almost undetectable in the mature 
epidermis and deregulated TAp63 results in hyperproliferation and failure of terminal 
differentiation (Koster et al., 2004; Koster et al., 2006; Liefer et al., 2000).  
 
 5 
 
 
 
 
 
 
 
Figure 2. Deletion of the p63 gene in mice 
A. Sagittal view of E18.5 embryo wild type (WT) and B. p63-/- embryo shows truncated 
limbs, cleft palate and transparent skin (Denoted by white arrows).  
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There are two distinct interpretations of roles of p63 in embryonic skin 
developmental defects: one is that p63 is essential for epidermal differentiation and 
another one is that p63 is critical for maintenance of epidermal stem cell renewal (Mills 
et al., 1999; Yang et al., 1999). Since those knock out mice do not possess any of p63 
isoforms, it is difficult to accurately predict which isoforms play an important role in 
epidermal development. 
However, the Flores laboratory (Su and Flores, 2009; Su et al., 2009b) 
demonstrated that TAp63 plays significant roles in skin development using a TAp63-/- 
mice model. To generate TAp63 knockout mice, a conditional knockout strategy was 
used and uses it to ablate TAp63 in the germline (TAp63-/-) or in keratin 14 expressing 
cells in the basal layer of the epidermis (TAp63fl/fl;K14Cre+) (Su et al., 2009b). TAp63-/- 
mice have developed a fully differentiated epidermis during the embryonic stage, 
whereas they showed premature aging and developed skin ulcerations, spontaneous 
blister at adulthood, senecesence of hair follicle-associated dermal and epidermal cells, 
delayed in wound healing and a decrease in hair morphogenesis (Su et al., 2009b). These 
phenotypes are due to loss of TAp63 that result from premature depletion of epidermal 
and dermal precursor cells capacity (Su et al., 2009b). TAp63-/- dermal precursor cells 
and epidermis prematurely senesced and showed genomic instability, indicating TAp63 
plays essential roles in maintaining epidermal stem cells with an appropriate balance of 
senescence event and genomic stability. 
 7 
In tumorigenesis, there is debate about the role of TAp63. The Roop laboratory 
reported that the expression of TAp63 in epithelial tumors is high, whereas expression of 
TAp63 is lower in the mature epidermis (Koster et al., 2006; Liefer et al., 2000). By the 
gene switch system, overexpression of TAp63 caused hyperproliferation with 
accelerating tumorigenesis but did not cause genomic instability arguing that TAp63 is 
as a proto-oncogene in epithelial tissue (Keyes et al., 2006; Koster et al., 2006). By 
contrast, the Jacks laboratory and others argued that TAp63 is a tumor suppressor when 
responding to apoptosis by irradiation (Flores et al., 2005; Flores et al., 2002; Park et al., 
2000; Urist et al., 2002). This opposing interpretation results from the lack of isoform 
specific animal model since both groups used overexpression or knock down in wild 
type background.  
Recently, the Flores laboratory generated TAp63 specific knock out mice and 
showed that TAp63 plays roles in senescence and tumor suppression and also controls 
metastasis which is controlled by dicer, a microRNA processing enzyme (Su et al.; Su 
and Flores, 2009; Su et al., 2009b). TAp63 coordinately regulates Dicer and miR-130b 
transcription in tumorigenesis and metastasis. Down modulation of Dicer and miR-130b 
remarkably affected the metastatic potential of TAp63-/- cells, suggesting that TAp63 
plays a key role as a regulator of microRNAs during tumorigenesis and metastasis. This 
data clearly demonstrated that TAp63 is a tumor suppressor (Su & Chakravarti et al., 
2010). 
 
1.2.2. The role of ΔNp63 isoforms  
 8 
 p63, unlike p53, is known for its role in the development and differentiation of 
epithelial surfaces (Mills et al., 1999; Yang et al., 1999). So the main role of p63 lies in 
the regulation of epithelial development, particularly in the formation of the epidermis 
(Candi et al., 2007a), whereas its function in cancer is less clear. 
 ΔNp63 isoforms are transcribed using an alternative promoter of the gene (exon 
3’) and it lacks the transactivation domain (Yang et al., 1998).  Different p63 isoforms 
have different functional properties. ΔNp63 is the predominant isoform of p63 in 
epithelial tissue during embryonic development and even throughout life (Candi et al., 
2007b). During mouse embryogenesis, the epidermis develops from a single-layered 
epithelium which expresses keratin 18 (K18) (Candi et al., 2007a). Stratification starts at 
embryonic day E9.5 when the first stratification markers, K5 and K14, are expressed. 
Epidermal stratification and maturation are complete by E19.5. p63 is necessary to 
achieve the terminal differentiation of epidermis. p63 proteins are mainly expressed in 
the basal layer, the expression of ΔNp63 starts from E8.5 before stratification begins 
(Laurikkala et al., 2006). The current data do not clearly indicate whether ΔNp63 
modulates the stem cell or the differentiation compartment.  
 The ΔNp63 gene has been implicated as an oncogene (Crook et al., 2000; Senoo et 
al., 2001) depending on the cellular context. Elevated levels of ∆Np63 correlate with 
tumor aggressiveness (Candi et al., 2007a; Candi et al., 2007b; Flores, 2007; Flores et 
al., 2005). Previously, ΔNp63 isoforms were found to induce cell proliferation and result 
in tumor and accelerated tumor growth (Massion et al., 2003; Yamaguchi et al., 2000). 
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ΔNp63 possesses dominant negative activity against p53, and the maintenance of cell 
proliferation may rely on inhibition of endogenous p53 function (Truong and Khavari, 
2007). However mechanistic roles of ΔNp63 in tumorigenesis and epidermal 
differentiation have not been fully elucidated. 
 
1.3. The roles of p63 in embryonic epidermal differentiation 
1.3.1. Skin stratification 
The skin is composed of two major compartments, the dermis and the epidermis, 
that form the outer-most-barrier to protect the body from pathogens and environmental 
insults. The epidermis forms from a single layered structure, and stratifies to multiple 
epithelial layers. The stratified epithelium has self-renewing capacity throughout life, 
and continuous turnover is mediated by epithelial stem cells that reside in the basal layer, 
which give rise to all epidermal cells. The epidermis forms four different layers: basal, 
spinous, granular and cornified layers (Marks, 2006). 
p63, especially ΔNp63, is highly expressed in the basal layer of the epidermis 
and has previously been shown to play a critical role in the development and 
maintenance of the epidermis (Cho et al. 2010; Koster et al., 2004). However the roles of 
ΔNp63 have not been well determined with regard to the regulation of stem cell renewal 
and appropriate differentiation because of their complexity. A recent study showed that 
TAp63 isoforms play an important role in dermal stem cell maintenance (Su et al., 
2009b). My preliminary data show that ΔNp63-/- skin expresses high levels of keratin 6 
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(K6), a marker for impaired stratified epithelial cells (Figure 3). K6 expression can also 
be implicated in hyperproliferative conditions, such as in wound healing or conditions 
that interfere with normal keratinocyte function (Rothnagel et al., 1999). This is 
suggesting that loss of ΔNp63 leads to a defect in normal stratification or differentiation. 
However, the roles of ΔNp63 have yet to be fully explained. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. K6 expression is high in ΔNp63-/- skin at E18.5. Western analysis was 
performed using protein from wild type and ΔNp63-/- skin at E18.5 embryos using 
antibody for K6. 
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1.3.2. The roles of p63 in limb development 
At the limb bud, limb formation begins by induction of fibroblast growth factor 
(FGF). FGF induces the formation of the apical ectodermal ridge (AER) and later it 
controls the apoptosis that is necessary to remove webbing between digits to form 
defined digits (Yonei-Tamura et al., 1999). During this interval of limb bud formation 
from embryonic day 9.5 to 12 (E9.5 to E12), expression of p63 is evident in the limb 
buds included in the apical ectodermal ridge (AER) at E8.5 (Koster et al., 2004; 
Laurikkala et al., 2006; Mills et al., 1999; Yang et al., 1999).  The high levels of p63 
expression in the AER suggest a potential role for p63 in maintaining the structure or 
function of this specialized ectoderm (Koster et al., 2004; Mills et al., 1999; Yang et al., 
1999). The AER is a region specified by expression of certain homeobox genes and T-
box genes. Fore- and hind-limbs are specified by the anterior/posterior axis and secretion 
of the transcription factors, T-box 5 and T-box 4, respectively (Ohuchi et al., 1998; 
Rodriguez-Esteban et al., 1999). Limb formation results from a series of epithelial-
mesenchymal transitions (EMT) between the limb bud mesenchymal cells (Hall, 2000a, 
b).   
 
1.4. p63 point mutations  in Human diseases 
Interestingly, humans carrying dominantly inherited point mutations of p63 in the 
DNA binding domain or SAM domain develop ectodermal dysplasias (Figure 4) 
(Barrow et al., 2002; McGrath et al., 2001). SAM domains are involved in protein-
 12 
protein interactions and play a role in developmental regulation. Ectodermal dysplasia in 
EEC syndrome (ectrodactyly-ectodermal dysplasia-cleft syndrome), which has mutations 
in the DNA binding domain of p63, affects the formations of skin, hair, teeth and other 
limb mammary development. AEC syndrome (ankyloblepharon-ectodermal dysplasia-
clefting syndrome) is also one of p63 dominant mutant diseases in the SAM domain in 
humans that commonly has chronic inflammatory dermatitis of the scalp. The p63 
dominant mutation in humans gives rise to a phenotype that resembles that of p63 knock 
out mice and these two diseases commonly have disfiguration of the limbs, cleft palate 
and skin dermatitis; however, the underlying mechanism remains elusive. 
To determine whether this human disfiguring phenotype is p63 isoform specific 
will be very interesting and help understand the role of p63 in human disfiguring 
diseases. Recently, the Flores laboratory generated TAp63 knock out mice that have fully 
developed limbs, mouth and skin (Su et al., 2009b). ΔNp63 might be a very important 
regulator of human disfiguring diseases and generation of ΔNp63 knock out mouse will 
provide a good animal model to study.  
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Figure 4. Phenotypic features of patients with AEC or EEC syndromes with p63 
dominant mutations 
A. Bilateral cleft lip and sparse hair (shown); cleft palate and hypodontia (not shown) 
(McGrath et al., 2001), B. A newborn with partial fusion of the eyelids 
(ankyloblepharon) (Barrow et al., 2002) and C. Bilateral ectrodactyly of the feet 
(McGrath et al., 2001). Reproduced and modified with permission from Barrow et 
al., 2002; McGrath et al., 2001 and Copyright clearance center 
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1.5. Stem cell maintenance  
All animals and land plants are multi-cellular organisms that have stem cells to 
maintain tissue homeostasis. Stem cells are defined with two characteristics; self-
renewal to maintain the precise number of cells and the ability to differentiate into a 
diverse specialized cell types. Mammalian stem cells are classified into two broad types: 
embryonic stem cells and adult stem cells. Embryonic stem cells are pluripotent and 
differentiate to diverse cell types whereas adult stem cells (called a somatic stem cell) 
are thought to maintain and repair the tissue or organ.  
This pluripotency is regulated by multiple transcription factors such as Oct4, 
Sox2, Nanog and others (Looijenga et al., 2003; Niwa, 2009; Rodda et al., 2005; Zaehres 
et al., 2005). In the oocyte, Oct4 is active as a maternal factor and it remains active 
through the embryonic stages before commitment to tissue organogenesis (Niwa, 2009). 
The expression of Oct4 is critical for governing pluripotency in order to keep the embryo 
away from differentiation in mice. Oct4 binds the octamer (ATTTGCAT) in the 
promoter regions of specific target genes. Oct4 and Sox2 form a heterodimer and Sox2 
acts like a transcription co-factor to turn on Nanog expression (Grinnell and Bickenbach, 
2007; Grinnell et al., 2007; Racila et al.).   
The expression of Oct4 is associated with undifferentiated phenotypes, since it 
has been shown that it is capable of reprogramming somatic mouse keratinocytes to 
become more like embryonic stem (ES) cells (Grinnell and Bickenbach, 2007; Grinnell 
et al., 2007; Racila et al.). Nanog is associated with pluripotent phenotype. Therefore, 
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Nanog is also extinguished upon differentiation (Grinnell and Bickenbach, 2007; 
Grinnell et al., 2007).  
p63 is highly expressed in the basal layer of the epidermis where epidermal stem 
cells reside and previously has been shown to play a critical role in epidermal 
development and maintenance (Mills et al., 1999; Yang et al., 1999).  Specially, TAp63 
knock out mice show premature depletion of precursor cells in the dermis and epidermis 
(Su et al., 2009b). However the roles of ΔNp63 in epidermal stem cell compartment 
remain uncertain. According to previous studies, I hypothesize that ΔNp63 plays 
important roles in the epidermal stem cell compartment.  
 
1.6. Asymmetric Cell division 
 During embryonic development, asymmetric cell divisions expand the diversity 
of cell types. Stem cells also divide asymmetrically to produce two distinct daughter 
cells. One daughter cell keeps its ‘stemness’ to give rise to equivalent cell fates and the 
other daughter cell differentiates to give rise to different cellular fates (Lambert and 
Nagy, 2002). Self-renewal of stem cells is an example of asymmetric division (Ulloa-
Montoya et al., 2005). Asymmetric cell divisions take place not only in embryonic stem 
cells but also in somatic cells to contribute to aging of the organism through the human 
and mice life span. Stem cells are precisely controlled depending on the rate of depletion 
of differentiated cells. In this way the production of differentiated cell types is precisely 
balanced by renewal of the stem cell population (Hall, 1989; Hall and Watt, 1989).  
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Asymmetric cell division is an example of biological cell polarization events and 
plays fundamental roles in precisely regulating various progenitor cells and maintenance 
of fully differentiated functional cells such as epithelial cells (Figure 5). Basal layer 
cells of epidermis function as skin stem cells and asymmetric vs. symmetric divisions 
result from regulation of spindle orientation. Asymmetric cell divisions result in 
asymmetric localization of proteins, RNA transcript and other macromolecules between 
daughter cells. For instance, β1-integrin or α-catenin null mice, basal epidermal cells 
lose their polarity resulting in misorientation of their spindles, demonstrating the 
importance in stem cell polarity and oriented divisions. 
 In Drosophila, asymmetric cell division was studied in neuroblast development 
where asymmetric divisions generate neuroblasts or glia. This event is precisely 
regulated by two apically localized multi-protein complexes, which are evolutionarily 
well conserved. In Drosophila, the Insc-Pins-aPKC complex is required for correct 
execution of the asymmetric division (Chia et al., 2001; Yu et al., 2002). 
In mammalian epithelial cells, there is a homologue of Pins, LGN (named after 
the repetitive Leu-Gly-Asn tripeptide in the protein), which is composed of seven 
tetratricopeptide repeats in the N-terminal region, and in the C-terminus four GoLoco 
motifs (G-protein regulatory motif)	  for binding to Gα that appears to control asymmetric 
cell-fate decision.  
In contrast to mammalian Par 3 (partition defective protein 3) and Pins, little is 
known about mammalian homologues of Insc. The C. elegans Par protein complex is 
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highly conserved across species including mammals (Izumi et al., 1998; Joberty et al., 
2000; Johansson et al., 2000; Kemphues, 2000; Kemphues et al., 1988a; Kemphues et 
al., 1988b); however, it is unclear whether this polarity protein complex regulates 
asymmetric cell division of progenitors.  Although the human Insc gene has been 
described based on analyses in silico, the structure and function of the gene products 
remain to be elucidated.  
Lechler and Fuchs describe the characterization of the mouse homolog of 
Inscuteable, mInsc, and find that protein complexes containing LGN, mInsc, and Par3 
localize to the apical cortex of perpendicularly dividing basal cells of epidermis (Lechler 
and Fuchs, 2005). Asymmetric cell divisions play important roles in differentiation and 
proliferation in skin. They also show that p63 null epidermal cells have a defect in 
asymmetric cell division indicating that p63 implicates asymmetric cell divisions 
(Lechler and Fuchs, 2005). However specific roles of p63 to regulate of these genes 
complex largely remain to be elucidated during embryonic epidermal development.  
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Figure 5. A schematic model of asymmetric cell division of epidermis and terminal 
differentiation during embryo development. 
The major role of cell division in normal adult skin is to maintain the rate 
between production and loss of cells through injury or death, thereby maintaining cell 
number at an approximately constant level, which is called homeostasis (Hall, 1989; 
Hall and Watt, 1989). The entire epidermis is continuously replaced by new cell growth 
from the basal cell layer to the top of the granular cell layer by terminal differentiation: 
this process is called cornification (Miller et al., 2006; Candi et al., 2005). The cells of 
the basal layer divide in an asymmetric way: one daughter cell keeps stemness that 
resides on basal layer and the other daughter cell undergoes differentiations that migrate 
to spinous layer and keeps going to differentiation event (Cho & Flores, unpublished).  
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1.7. MicroRNA biogenesis and regulation  
MicroRNA (miRNA) functions are implicated in numerous biological stages and 
human diseases: developmental timing, embryogenesis, programmed cell death, 
proliferation, stem cell differentiation, organogenesis, and angiogenesis, hematopoiesis, 
tumorigenesis and viral defense (Alvarez-Garcia and Miska, 2005; Lim et al., 2003). 
miRNA genes are transcribed by RNA polymerase II as long primary transcripts (pri-
miRNAs) (Kim, 2005). Then pri-miRNAs are processed in the nucleus by the RNase III 
enzyme Drosha, acting with its double-stranded RNA binding partner protein DGCR8 
(in vertebrates) or Pasha (in invertebrates), called a microprocessor. The microprocessor 
complex cleaves pri-miRNAs to generate small stem-loop structures called precursor 
miRNAs (pre-miRNAs), which are then processed further by a second RNase III enzyme 
(Dicer) (Sontheimer and Carthew, 2005)	  into mature miRNAs (Figure 6).  
MicroRNAs (miRNAs) are on average only 22 nucleotides long and are found in 
all eukaryotic cells. miRNAs post-transcriptionally regulate target mRNAs by binding to 
complementary sequences, resulting in repression of protein expression and gene 
silencing. Thousands of miRNAs are encoded in the human genome and regulate more 
than 30% of human genes. This occurs when mature miRNAs become coupled with a 
multiple-protein nuclease complex called the RNA-induced silencing complex (RISC). 
Once incorporated into the RISC, the miRNA is situated to regulate target genes by 
degradation of the mRNA through direct cleavage or by inhibiting protein synthesis. 
         Eukaryotic organisms have well conserved miRNAs, approximately half of known 
microRNAs, that reside in non-protein coding RNAs (intron and exon) or within the 
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intron of protein coding genes. RNA polymerase II transcribes miRNA genes, generating 
long primary transcripts (pri-miRNAs). Subsequently, the process yields mature 
miRNAs through two steps involving RNase-III enzymes, Drosha and Dicer, and 
companion double-stranded RNA-binding domain (dsRBD) proteins (Figure 6).  
In the nucleus, Drosha forms a complex with DGCR8, which recognizes double 
stranded RNA and processes the long primary miRNA, yielding premature miRNA (pre-
miRNA) with a hairpin structure composed of approximately 70 nucleotides in length. 
The premature miRNA with hairpin structure is exported to the cytoplasm by exportin 5, 
where they are processed 19-25 nucleotides long miRNA duplex structures by Dicer (Yi 
et al., 2003); (Sontheimer and Carthew, 2005). The double stranded RNAs are 
incorporated into the RISC complex, which regulates protein expression. In most cases 
studied so far, animal miRNAs are not completely complementary to their mRNA 
targets. They seem to inhibit protein synthesis while retaining the stability of the mRNA 
target (Ambrosio et al., 2004; Lee et al., 2004). Target gene transcripts are regulated by 
multiple miRNAs and an individual miRNA targets numerous transcripts. DGCR8 only 
processes miRNAs while Dicer processes both miRNAs and endogenous siRNA.  
The Flores laboratory (Su & Chakravarti et al., 2010) showed that TAp63 
regulates Dicer during development and tumor metastasis and others showed that 
miRNA203 down regulates ΔNp63 in differentiated epidermal cell layers, including the 
spinous layer. However ΔNp63’s role in microRNA biogenesis and regulation remains 
to be elucidated.  
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Figure 6. The Canonical pathway of microRNA (miRNA) biogenesis  
The canonical microRNA maturation processing pathway has been viewed as 
linear and universal to vertebrate microRNAs. This maturation pathway implicates the 
production of the precursor microRNA from cleavage of primary microRNA by the 
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microprocessor complex Drosha–DGCR8 (also called Pasha) in the nucleus. The 
resulting precursor microRNA hairpin structure is exported from the nucleus to the 
cytoplasm by the Exportin-5-Ran-GTP. In the cytoplasm, the RNaseIII Dicer in complex 
with TRBP (the double-stranded RNA-binding protein) cleaves the precursor microRNA 
to a mature microRNA. The RNA-induced silencing complex (RISC), with the mature 
miRNA, silence target mRNAs through mRNA cleavage, translational repression or 
deadenylation, whereas the passenger strand (black) is degraded (Winter et al., 2009) 
(Reproduced with a permission from copyright clearance center).	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1.8. Genes that play critical roles in epidermal stem cells 
1.8.1. Ink4a –Arf  
Arf is a tumor suppressor located at the INK4a/Arf locus. p16Ink4a and p19Arf are 
encoded from the same locus and are transcribed from alternative reading frames. Ink4a 
and Arf mRNA are composed of three exons. Arf is regulated in response to aberrant 
growth signaling, apoptosis, and cell cycle arrest (Sherr and McCormick, 2002). It 
accumulates in the nucleolus and forms a complex with MDM2. This complex initiates 
p53 dependent cell cycle arrest and apoptosis. Important roles of the Ink4a/Arf locus, 
which are epigenetically silenced by polycomb complexes, have been implicated in the 
maintenance of hematopoietic stem cells (HSCs) and neural stem cells (NSCs) (Bracken 
et al., 2007; Bruggeman et al., 2005; Molofsky et al., 2005; Molofsky et al., 2003).	  By 
contrast, the overexpression of polycomb complex results in aggressive metastatic 
cancer. Loss of bone marrow-derived HSCs result from the Ink4a-Arf locus being 
epigenetically sequestered by polycomb complexes, such as CBX7, CBX8 and Bmi 
(Bracken et al., 2007; Bruggeman et al., 2005). Bmi knock out mice rescue the bone 
marrow loss of Ink4a-Arf-null mice (Bruggeman et al., 2005; van der Lugt et al., 1994) 
and likewise, this occurred in neural stem cells (NSCs), indicating Bmi1 is essential for 
the self-renewal of hematopoietic and neural stem cells. These data also implicate 
inhibition of the Ink4a-Arf locus as an essential event in the process of stem cell renewal. 
Therefore, inhibition of Ink4a-Arf may also take place not only in HSCs and NSCs, but 
also other stem cells like those that reside in the epidermis. However putative repressors 
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other than Bmi1 in other stem cell lineages have yet to be identified. p63, which is highly 
expressed in the basal layer of the epidermis (Fuchs, 2008; Senoo et al., 2007). We 
hypothesized that p63 represses Ink4a-Arf in epidermal stem cells.  
 
1.8.2. Brachyury 
Brachyury is a transcription factor within the T-box complex of genes, which in 
mammals is comprised of 18 T-box genes. A specific DNA element (a near palindromic 
sequence TCACACCT) is recognized and bound to T (brachyury) through a region in its 
N-terminus (called the T-box). Brachyury heterozygous mutants have shortened tails and 
brachyury homozygous mutants are lethal around embryonic day E10 due to defects in 
mesoderm formation, notochord differentiation and the absence of the forelimb bud. By 
genome nomenclature of human and mouse, brachyury is used as a gene symbol and the 
gene is called as T although brachyury is maintained as the gene description. Brachyury 
has a conserved role in the establishment of the anterior-posterior axis. It also defines the 
mesoderm during gastrulation. Brachyury is required for mesoderm formation and 
cellular differentiation and brachyury mutant mice exhibit a disruption in the apical 
ectodermal ridge (AER) morphogenesis. The AER is a thickened ridge of ectoderm that 
is essential for limb morphogenesis (Johnson and Tabin, 1997; Kengaku et al., 1998). In 
mice, brachyury is expressed in the inner cell mass of the blastocyst stage embryo (but 
not in the majority of mouse embryonic stem cells) in early development and its 
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expression is localized to the node and notochord in later development. This indicates 
that brachyury plays diverse roles with critical functions during embryonic development.  
Recently, brachyury has been shown to be upregulated in a variety of tumors and 
tumor cell lines, including those of the small intestine, stomach, kidney, bladder, uterus, 
ovary, testis, lung, colon, and prostate (Palena et al., 2007), and chordoma, a rare 
malignant bone tumor (Vujovic et al., 2006; Yang et al., 2009). Expression of the 
brachyury gene is used as a diagnostic marker of a malignant tumor, chordoma, which 
arises from remaining notochordal cells accumulated in the vertebrate. Furthermore, 
duplication of brachyury in the germ line confers major susceptibility to chordoma. 
Brachyury also regulates epithelial to mesenchymal transition (EMT) and mesenchymal 
to epithelial transition (MET), which, in addition to being critical processes in 
development, are also involved in tumor metastasis (Liu et al., 2003a; Palena et al., 
2007; Yang et al., 2009) that results from overexpression of brachyury (Liu et al., 2003a; 
Palena et al., 2007; Yang et al., 2009).  
Our previous genome-wide analysis using a 15,000 cDNA microarray in the 
absence of p63 mouse embryonic fibroblasts (MEFs) identified brachyury as a putative 
transcriptional target of p63 (Lin et al., 2009). Brachyury is an attractive target of p63 
based on the p63 mutant mouse phenotypes. During the interval of limb bud formation 
from embryonic day 9.5 to 12 (E9.5 to E12), p63 expression is evident in the limb buds 
including in the apical ectodermal ridge (AER).  
 
 27 
1.8.3. DGCR8 
Drosha and Dicer are required for microRNA processing. DGCR8 contains a 
double-stranded RNA (dsRNA) binding domain and is thought to recognize and bind 
pri-miRNA to stabilize it for processing by Drosha. DGCR8 only processes miRNAs 
while Dicer processes both miRNAs and endogenous siRNA (Suh et al.).	   Dicer-/- and 
Dgcr8-/- have shown that miRNAs have essential roles in the proliferation and 
differentiation of embryonic stem cells (ESC). When embryonic stem cells differentiate, 
they must both silence the ESC self-renewal program and activate new tissue-specific 
programs (Melton et al.; Suh et al.; Yi et al., 2009). In the absence of DGCR8, mouse 
ESCs fail to silence self-renewal. Dgcr8-/- ESCs were unable to silence Oct4, Sox2 and 
Nanog gene expression resulting in a defect in differentiation. Conditional knock out of 
Dcgr8 (K14cre-Dgcr8fl/fl: designated to Dgcr8cko) in animal skin showed a defect in 
epidermal stratification and differentiation resulting in dry skin. Hair follicle growth 
occurred in the opposite orientation in Dgcr8cko compare to wild type (Figure 7).  
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Figure 7. The Hair follicle morphology of Dgcr8 cKO and Dicer cKO 
A. P6 Dgcr8 and Dicer cKO skins display evaginating hair germs (hg) that appear as 
balls of undifferentiated cells (arrows) that distort the epidermis (epi). (Scale bar, 10 
µm.) and B. Immunofluorescence identifies germs molecularly by transcription factor 
Lef1 and by hemidesmosomal β4 integrin (nonspecific dermal staining is caused by the 
secondary antibody). (Scale bar, 20 µm.). Reproduced with permission from Yi R et 
al. PNAS 2009;106:498-502 
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The epidermal cells from Dgcr8cko were hyperproliferative and showed delayed-
differentiation. It was resulting from incomplete stratification and differentiation, that 
later, caused death by desiccation (Yi et al., 2009). This is similar to the phenotype of 
ΔNp63 null mice. 
According to  others studies, application of stem cell activity has been used for 
some considerable time. However, ex-vivo grafted keratinocytes have limitations, and do 
not satisfy the homeostatic view of stem cell activity. Because of this limitation, 
understanding the developmental steps leading to the generation of epidermal stem cells 
that raise more hope in human embryonic stem cell research and the characterization of 
the key signaling pathways involved in skin morphogenesis will be beneficial for 
therapeutic aspects. For instance, in zebrafish studies, p63 plays roles as an inducer of 
epidermal development and an inhibitor of neuroectodermal formation, and later it is 
required for epidermal cell proliferation. To understand the roles of p63 in mammalian 
epidermal cell proliferation, p63 knock out mice were generated by two groups. One 
group hypothesized that p63 is necessary for maintenance of stem cells (Yang et al., 
1999; Senoo et al. 2007), whereas the second suggests epidermal commitment and 
stratification impairments (Mills et al., 1999; Koster et al. 2004, 2007a). The two 
hypotheses and the nature of the p63 isoform involved in these critical embryonic steps 
remain highly controversial (Koster et al. 2007b).  
TAp63-/- mice have already been generated and characterized with respect to 
epidermal development (Su et al., 2009). TAp63-/- mice exhibit genomic instability, 
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dermal stem cell hyperproliferation, and depletion of the epidermal stem cell 
compartment, whereas TAp63-/- embryonic skin has a fully developed epidermis. TAp63 
transcriptionally regulates Dicer, which is a critical RNaseIII enzyme that processes 
microRNAs and endogenous siRNAs. TAp63 is a stress response gene and its expression 
in the epidermis is undetectable in the absence of stress. However ΔNp63-/- mice have 
different phenotypes than TAp63-/- mice in embryonic development, especially in the 
epidermis. ΔNp63+/- epidermis has expansion in basal layer and epidermis of ΔNp63+/- 
and ΔNp63-/- has an aberrant hyperproliferation. Expression of the pluripotency 
regulating genes, Oct4, Sox2 and Nanog were high in ΔNp63 deficient epidermal cells, 
even though these are supposedly somatic differentiated cells. The phenotypes of TAp63 
null mice and the difference between TAp63-/- and ΔNp63-/- mice led me to hypothesize 
that TAp63 and ΔNp63 function differentially in the epidermal development. My 
hypothesis is that ΔNp63 is required for embryonic epidermal differentiation through 
silencing pluripotency genes.   
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Chapter 2.  
Materials and Methods 
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Chapter 2. Materials and Methods 
 
Generation of ΔNp63 Conditional Knockout Mice 
The cre-loxP strategy was used to generate the ΔNp63 conditional knockout 
allele (ΔNp63fl). Genomic p63 DNA from intron 3 to intron 3’ was amplified from a 
BAC clone DNA (BAC RP23-186N8, Children's Hospital Oakland Research Institute). 
LoxP sites flanking exon 3’ of p63 and neomycin (neo) gene flanked by frt sites inserted 
in intron 3’ were cloned into pL253 (Liu et al., 2003). Mouse embryonic stem cells 
(ESCs) were analyzed by Southern blot analysis for proper targeting of the ΔNp63 allele.  
Chimeras resulting from ESC clones injected into C57BL/6 blastocysts were 
mated with C57BL/6 albino females and genotyped as described below. Mice with germ 
line transmission of the targeted allele (conditional, flox neo allele, fn) were crossed to 
the FLPeR mice to delete the neo cassette (Farley et al., 2000). Resulting progeny were 
intercrossed with Zp3-Cre (C57BL/6) (Lewandoski et al., 1997) transgenic mice. 
ΔNp63fl/+;Zp3-Cre females were mated with C57BL/6 males to generate ΔNp63+/- 
mice. The ΔNp63+/- mice were intercrossed to generate ΔNp63-/- mice. All procedures 
were approved by the IACUC at U.T. M.D. Anderson Cancer Center. 
 
Genotyping 
Genomic DNA from tail biopsies was genotyped by Southern blot analysis by 
digesting genomic DNA with BglI or by PCR using the following primers and annealing 
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temperature: 1.) for wild-type (388bp): wt-F, 5'- ACAGTCCTCTGCTTTCAGC-3' and 
wt-R (fl-R), 5'- CACACAGCA CTGGCCTTGC -3’, annealing temp: 62°C, 2.) for 
ΔNp63flox (256bp): fl-F, 5' – TTAGGTGGA TCCCTAGGAAGAG - 3' and fl-R (wt-
R), 5' – CACACAGCACTGGCCTTGC - 3', annealing temp: 62°C, and 3.) for 
ΔNp63KO (468bp): ko-F, 5’- TACAGCTCCTGGAGGATC CCATGC-3’ and wt-R, 
annealing temp: 62°C. Primers used to genotype the CRE gene are as follows: Cre-F, 5' 
–TGGGCGGCATGGTGCAAGTT - 3' and Cre-R, 5' – 
CGGTGCTAACCAGCGTTTTC - 3', annealing temp: 60° C. The PCR products were 
electrophoresesed on a 1% agarose gel.  
 
Mouse husbandry 
p63+/- mice on (C57BL/6_129SvJae) a background enriched for C57BL/6 (95%) 
(Yang et al, 1999; Flores et al, 2005) were intercrossed with Ink4a-/- (Sharpless et al., 
2001), ArfGFP/GFP (Zindy et al., 2003a) or p53-/- (Jacks et al., 1994) mice to obtain 
compound mutant mice and embryos of the following genotypes: Ink4a-/-;p63-/-, 
ArfGFP/GFP;p63-/-, and p53-/-;p63-/-. Wild type and p63-/- mice were also generated from 
each cross and analyzed. All procedures were approved by the IACUC at U.T. M.D. 
Anderson Cancer Center. 
 
Histology and immunostaining of E18.5 embryos 
Pregnant females at day E18.5 of gestation were injected with BrdU (100 mg / 
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gram of total body weight) 3 times of 1 hour interval (Su et al., 2009b). Embryos were 
extracted 1 hour later after the last injection and fixed in 10% formalin at room 
temperature for 18 hours.  The next day fixed embryos were changed into 70% ethanol 
for overnight. Fixed embryos were embedded in paraffin, sectioned, and stained with 
hematoxylin and eosin (H&E) for microscopic analysis. For immunofluorescence (IF), 
paraffin-embedded sections were rehydrated in xylene and gradually decreasing 
concentrations of ethanol (100%~70%). Sections were subjected to antigen unmasking 
in citrate buffer unmasking solution (Vector Laboratory) followed by incubation with 
blocking solution for 1hour at room temperature, and 18 hour incubation at 4oC with the 
following primary antibodies:  K5 (1:1000) (Abcam), K14 (1:500) (LifeSpan 
BioSciences), K10 (1:1000) (Covance), K15 (1:1000) (Abcam), filaggrin (1:1000) 
(Abcam), collagen IV (1:80) (Abcam), Lef1 (1:200) (Cell Signaling), ΔNp63 antibody 
(1:1000) (BioLegend) and Lhx2 (1:200) (SantaCruz). For staining with collagen IV 
antibody, unmasking was performed with Protease XXV (Fisher, AP-9006-002) at 37 oC 
for 10 min.  
For immunofluroescence, visualization was performed using an anti-rabbit 
secondary antibody conjugated to Texas-red (1:5000) (Jackson ImmunoResearch 
Laboratories), an anti-guinea pig secondary antibody conjugated to FITC (1:1000, 
Jackson Immuno- Research), or an anti-chicken secondary antibody conjugated to Alexa 
488 (1:1000) (Molecular Probes) followed by counterstaining with DAPI (Vector 
Laboratory) or ToPro3 (Invitrogen). Incorporation of BrdU was analyzed using the BrdU 
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detection kit II (Roche). For BrdU analysis by immunocytochemistry, a FITC conjugated 
BrdU antibody (1:200) (TEX-Gene) was used. GFP immunofluorescence was performed 
on frozen sections prepared from E18.5 embryos. Briefly, the epidermis was peeled from 
day 18.5 embryos and frozen in OCT compound (Tissue Tek). Frozen sections were 
fixed in 2% formaldehyde/0.2% glutaraldehyde solution for 2 min before incubation 
with anti-GFP (1:1000) (Invitrogen) at 4 oC overnight followed by incubation with anti-
rabbit secondary antibody conjugated to Texas-red (1:2000) (Jackson ImmunoResearch 
Laboratories) and counterstaining with DAPI (Vector Laboratory).  
For immunohistochemistry, visualization was performed using Vector VIP kit 
(Vector Laboratory). 
 
Mouse embryonic fibroblasts (MEFs) and keratinocytes isolation and culture  
Wild type, p53-/-, p63-/-, ArfGFP/GFP, and ArfGFP/GFP;p63-/- MEFs were isolated 
from embryos at day 13.5 and cultured in DMEM with 10%FBS as described earlier 
(Flores et al, 2002). Wild type, p63-/-, p53-/-;p63-/-, ArfGFP/GFP, ArfGFP/GFP;p63-/-, Ink4a-/-, 
and Ink4a-/-;p63-/-, ΔNp63-/- and ΔNp63fl/fl keratinocytes were isolated from E18.5 
embryos. Briefly, the skin was peeled off and incubated in dispase II (Roche) for 18 h at 
4 oC to separate the epidermis from the dermis. Epidermal sheets were minced into small 
pieces and incubated in 0.25% trypsin–EDTA (Gibco-BRL) for 20min at 37 oC. Cells 
were plated on mitomycin treated J2-3T3 feeder cells and cultured in F media (Sigma) 
supplemented as described earlier (Barrandon and Green, 1987; Flores et al., 2000). 
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Tumor cell lines  
Tumor cell lines were derived from p53+/- or p53+/- ;p63+/- mice with tumors of 
the indicated types. Each cell line was re-genotyped as described previously to assay for 
loss of heterozygosity (LOH) of p53 or p63 (Yang et al., 1998). The six tumor cell lines 
used are as follows: (1) Os-1 is derived from a metastatic osteosarcoma (p53-/-;p63+/- ). 
(2) Os-2 is derived from a non-metastatic osteosarcoma (genotype p53-/-) (3) Os-3 is 
derived from a metastatic osteosarcoma (genotype p53+/-;p63-/-), (4) RS is derived from a 
rhabodomyosarcoma (genotype p53+/-), (5) MAd is derived from a mammary 
adenocarcinoma (genotype p53+/-;p63-/-), and (6) LAd is derived from a lung 
adenocarcinoma (genotype p53+/- ;p63-/-). 
 
Chromatin immunoprecipitation (ChIP) 
Wild type and ΔNp63-/- keratinocytes were grown to near confluence on J2-3T3 
feeder cells in F media as described previously (Su et al., 2009b). Feeder cells were 
removed with 0.02% EDTA 24 hours prior to collecting keratinocytes for chromatin 
extraction. Cellular proteins were crosslinked to DNA using 1% formaldehyde and 
chromatin was prepared as described earlier (Flores et al., 2002). ChIP analysis was 
performed using a pan-p63 antibody (4A4, Abcam) and p53 antibody (FL-393) (Santa 
Cruz) as described previously (Flores et al., 2002; Su et al., 2009a). Each ChIP was 
performed in triplicate using keratinocytes from three embryos of each genotype. q-RT 
PCR was performed by using primers specific for the indicated regions of the DGCR8 
 37 
promoter:  Site1 -3393 - forward 5’-AGTCACCTTGGTGCC TCTCATAG-3’ and -3348 
-reverse 5’-AAACAGGTGGCAAGGCTTCTT-3’, Site2 -1459 - forward 5’-
CATTTTTTTCTGTGGATCTTTTGGT-3’ and -1397 - reverse 5’-CACAGGGCAGGC 
AGATCAG-3’, and nonspecific site -3893 - forward 5’-
CAAATCAAAATCTGCATCCATAGG -3’ and -3833 - reverse 5’-
GCCCTCCTGCCTGTAAACCT-3’ and LGN promoter: site1F 5’-
TGAAGGCATGAATAGAATGGGAAT-3’, site1R 5’-
GGAAAAGCAGAGATGGCGAAT-3’,  site2F 5’-TCCCACTTTTCGCCATCTG-3’, 
site2R 5’-TCCTCCGCCAACTAGAAGCTT-3’, site3F 5’- 
GCCCTGGTTGTCCTGGATCT-3’  and site3R 5’-	  
CAAGTGGGTCTCTGTGTGTTTGA-3’.  
Mouse embryo fibroblasts (MEFs) were grown to near confluence in 15 cm 
dishes. Cells were cross-linked with 1% formaldehyde for 10 min at 37°C in DMEM. 
The chromatin was prepared as described previously and diluted 10-fold in ChIP dilution 
buffer and incubated overnight at 4°C with 2 µg of p53 (FL-393) (Santa Cruz), p63 
(4A4) (Santa Cruz), or p73 antibody (IMG-246) (Imgenex) or 2 µg immunoglobulin G 
(IgG). Immunoprecipitated DNA was purified and PCR was performed using the 
primers flanking the identified p53/p63 consensus binding site, forward primer (5'-
AGTCTGATATGGCCGCGCAC-3') and reverse primer (5'-AAAGATTACACCTGG 
GTCCCTG-3'), and 58°C as the annealing temperature to generate a 279 bp amplicon. 
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Western blot analysis 
Total cell lysates were generated from keratinocytes or skin from 18.5day 
embryos.   50 µg total protein was electrophoresed on a 10% SDS PAGE and transferred 
to PVDF membrane as described previously. Blots were probed with anti ΔNp63 
(1:2000) (BioLegend), K5 (1:1000) (Abcam), K10 (1:1000) (Covance), filaggrin 
(1:1000) (Abcam), DGCR8 (1:200) (Abcam), p19Arf (5C3-1) (Bertwistle et al., 2004), 
GFP (1:1000) (Invitrogen) or p16Ink4a (1:200) (Santa Cruz) at 4oC for 18 hours 
followed by incubation for 1 hour at room temperature with goat anti-mouse or goat 
anti-rabbit secondary antibodies conjugated to horseradish peroxidase (1:5000) (Jackson 
Lab). Actin (Sigma 1:5000) was used as a loading control. Detection was performed 
using the ECL Plus Kit (Amersham) following the manufacturer’s protocol and x-ray 
autoradiography. 
Total cell lysates were generated from tumor cell lines (Os-1 and Os-2) 24 hours 
after transfection, or MEFs. 20 µg were electrophoresed on a 10% SDS PAGE and 
transferred to PVDF membrane as described previously. Blots were probed with anti-
p63 (4A4) (1:500) (Santa Cruz) at 4°C overnight followed by incubation for one hour at 
room temperature with goat anti-mouse secondary antibodies conjugated to horseradish 
peroxidase (1:5,000) (Jackson Lab). Anti-actin (Sigma 1:5,000) was used as a loading 
control. Detection was performed using the ECL Plus Kit (Amersham) following the 
manufacturer’s protocol and x-ray autoradiography. 
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RNA extraction and quantitative real–time PCR (q-RT PCR) 
RNA was prepared from the dermis/epidermis peeled from wild type, p63-/-, 
ArfGFP/GFP, ArfGFP/GFP;p63-/- , ΔNp63-/- or TAp63-/-  18.5 day embryos  and wild type, p63-
/- or TAp63-/- 9.5 day embryos using an RNeasy plus kit (Qiagen Ltd.). cDNA was 
synthesized from 2 ug of total RNA using TriZol (Invitrogen) according to the 
manufacturer’s protocol. The RNA levels of Ink4a, Arf, and GFP encoded by the 
cellular Arf promoter were determined by q-RT PCR and performed in triplicate using an 
ABI 7900 machine. The following primers were used for performing real-time PCR: 
Ink4a, p19Arf (Bruggeman et al., 2005), and GFP sense 5’-
GTCCGCCCTGAGCAAAGA-3’, GFP antisense 5’-TCCAGCAGGACCATGTGATC-
3’. Primers for GAPDH were used as an internal control. The primers for mOct4, mSox2, 
mNanog (Taube et al.), mDGCR8 (Han et al., 2009), mNestin (Pattyn et al., 2003), and 
mNeuN (Hu et al.) were used as described previously. Brachyury mRNA, sense 5'-
CGGTGCTGAAGGTAAATGTG-3', and antisense 5'-GTTGTCAGCCGTCACGAG T-
3' were designed by Cho (Cho et al., 2010). Primers for ΔNp63, TAp63 and GAPDH 
were used as described previously (Su et al., 2009b).  
 
Cloning of brachyury-luciferase reporter constructs.  
The brachyury promoter was amplified from BAC clones, RP24-530D23 and 
RP23-376B1 (Children’s Hospital Oakland Research Institute), and cloned into the 
pGL3 basic luciferase reporter vector (Promega). To generate the Brach1 luciferase 
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construct, primers were designed containing the p63 binding site shown by ChIP and 5' 
XhoI and 3' BglII cloning restriction enzyme sites: forward primer (5'-
CCGCTCGAGTGCGAGGCCACCTCGGCT-3') and reverse primer (5'-
GGAAGATCTCAAAGGAGCACCGAGATCGGG-3'). The primers to generate the 
Brach2 luciferase construct were designed to encompass the identified p63 binding site, 
exon 1 and intron 1 of brachyury and 5' XhoI and 3' BglII cloning restriction enzyme 
sites: forward primer (5'-CCGCTCGAGTGCGAGGCCACCTCGGCT-3') and reverse 
primer (5'-GGAAGA TCTAAGACAGCGCACGGCAGGA-3'). PCR amplicons were 
digested with XhoI and BglII and ligated into pGL3 basic (Promega). The 
QuickChange® Multi Site-Directed Mutagenesis kit was used to generate Brach1m 
using the Brach1 luciferase construct as a template and the following primers: forward 
5'-
CATTTTTCTCTTCCCCAGAGACTTACTTTTTTCGCGCTTTTCGGGAGTTCAAGT
G-3' and reverse 5'-
CACTTGAACTCCCGAAAAGCGCGAAAAAAGTAAGTCTCTGGGGAAGAGAAA
AATG-3'.  
To generate the Dgcr8 S luciferase construct, DNA was amplified from wild type 
mouse genomic DNA (C57BL/6) using primers containing the p63 binding site shown 
by ChIP and 5’ XhoI and 3’ BglII cloning restriction enzyme sites: (DGCR8- Luc F: 
XhoI 5’-CCGCTCGAGGCTTCTAGTTGTCTATTCC-3’, DGCR8- Luc R: BglII 5'- 
GGA AGATCTGCTCACCAGATAGCTTGGA -3') PCR amplicons were digested with 
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XhoI and BglII and ligated into pGL3 basic luciferase reporter vector (Promega). The 
QuickChange® Multi Site-Directed Mutagenesis kit was used to generate dgcr8 Sm-luc 
using the dgcr8 S luciferase construct as a template and the following primers: 1 forward 
5'-ATGCCTGTCTAAAGTCACTTTTGTGCCTCTCATAGGCCTG-3', 2 forward 5'-
GCATGTATCTCCTAAGAAGCTTTTCCACCTGTTTACAACACCAG-3', 3 forward 
5'-TGGTGCCTCTCATAGGCCTGTTTTTATCTCCTAAGAAGCCTTGC-3'. 
 
Dual-luciferase reporter assay  
Luciferase reporter assays were performed as described previously. p53-/-;p63-/- 
MEFs were plated on 6-well plates (3.5 x 105 cells per well). Twelve hours after plating, 
the MEFs were transiently transfected using Fugene HD (Roche) with 1 µg of Brach1, 
Brach2, Brach1m, dgcr8S or dgcr8 Sm, 0.5 µg of Renilla luciferase plasmid (transfection 
control), and 0.5 µg plasmids encoding the p63 isoforms [TAp63α, TAp63β, TAp63γ, 
ΔNp63α, ΔNp63β or ΔNp63γ or 0.5 µg of empty vector (pcDNA3)]. After 24 hr, cells 
were harvested, lysed with manufacturer’s protocol and luciferase activity was measured 
using the Dual-Luciferase Reporter Assay system (Promega) and a Veritas microplate 
luminometer (Turner BioSystems). Each experiment was performed in triplicate. 
 
Keratinocytes proliferation assays 
Keratinocytes, wild type, p63-/-, Ink4a-/-, ArfGFP/GFP, Ink4a-/-;p63-/-, 
ArfGFP/GFP;p63-/- and p63-/-;p53-/- of 1 X 104 were plated in triplicate on mitomycin 
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treated J2-3T3 feeder cells. Keratinocytes were counted every day for 8 days. 
Keratinocytes were also subjected to serial passages at 5-day intervals. After isolation, 1 
X 104 keratinocytes were plated in triplicate, passaged, and the cumulative number of 
population doublings was calculated. 
After adeno-Cre virus infection for 24hours, passage-0 keratinocytes, wild type and 
ΔNp63Δ/Δ, were plated at a density of 4 X 105 in 10cm dish on J2-3T3 feeder cells. 
Keratinocytes were trypsinized and counted at 5 and 10 days.  
 
Proliferation assay (Tumor cell lines) 
Os-1 and Os-2 tumor cell lines were plated at a density of 1 x 105 cells in a 6-
well dish and transfected with p63-siRNA. Forty-eight hours after transfection, tumor 
cells in 6-well dishes were treated with 10 mM BrdU for 15 hours as described 
previously.16 Cells were fixed with 70% ethanol and immunostained using anti-BrdU-
FITC (1:200) (GeneTex). DAPI was used as a counterstaining. The percentage of BrdU 
positive cells were calculated by counting the number of BrdU positive cells and 
dividing by the total number of cells with and without BrdU positivity in each well. Each 
experiment was performed in triplicate. 
 
Keratinocyte differentiation and neuronal cell differentiation assay 
Passage-0 ΔNp63fl/fl keratinocytes were plated at a density of 1 X 106 in 10cm 
dish on J2-3T3 feeder cells. When confluency of the cells reached 80%, keratinocytes 
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were infected with adenovirus-Cre-GFP (5000 particles per cell) to recombine ΔNp63 
allele (ΔNp63Δ/Δ) and adenovirus-GFP (Vector Development Lab, Baylor College of 
Medicine) was used as a control. After 24 hours, keratinocytes were trypsinized. 
Passage-1 keratinocytes were plated at a density of 1 X 106 in 10cm dish on J2-3T3 
feeder cells in F media supplemented with high calcium at a final concentration of  
(1.6mM) and refed every day for 3days. Differentiation was assessed using western blot 
analysis using antibodies against K5, K10 and filaggrin as described above. To test 
rescue differentiation defects in keratinocytes, 2µg of flag-DGCR8 was transfected into 
4 X 105 in 6 well dish ΔNp63Δ/Δ for 24hours and cultured in F media supplemented with 
high calcium condition (1.6mM) and refed with high calcium F-media every day for 
3days. For neuronal cell differentiation test, ΔNp63Δ/Δ epidermal cells with or without 
flag- DGCR8 transfection were cultured in neuroectodermal media as described in 2007 
paper. Neuronal cell differentiation was assessed using q-RT PCR for mNestin and 
mNeuN as described above.  
 
miRNA TaqMan assay  
Applied Biosystems TaqMan miRNA assays were employed to detect and 
quantify mature miRNAs using looped-primer real time PCR for miR145, miR 470., 
miR295, miR 302a and miR130b. Total RNAs were prepared from keratinocytes by 
TRIzol LS Reagent (Invitrogen). Two-step TaqMan MicroRNA Assay kit was used as 
described previously (Su and Chakravarti et al., 2010) 
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Clonogenic assay, rhodamine B and BrdU staining  
4 X 105 ΔNp63Δ/Δ epidermal cells were plated on mitomycin c (Roche)-treated 
J2-3T3 feeder cells in F media as described (Barrandon and Green, 1987; Flores et al., 
2000; Su et al., 2009b). Keratinocytes cultured for 7 days were trypsinized and some 
dishes were fixed in 10% formalin for 30min, and stained with 2% rhodamine B 
(Sigma). Some dishes were treated with 10 mM BrdU for 15 hr prior to harvesting. The 
BrdU treated cells were fixed in 70% ethanol for 30min and then denatured by 0.01N 
NaOH. Cells were double stained with anti-cytokeratin 5 (Abcam) (1:1000) and anti-
BrdU-FITC conjugated antibody (GeneTex, Inc.) (1:200). Secondary antibody used is 
anti-rabbit-Texas Red-conjugated (Jackson ImmunoResearch) (1:500).  
 
Murine p63 siRNAs assay.  
A murine p63 siRNA was designed spanning amino acids 134–141 of p63 (5'-
AAGAGACCGGAAGGCAGATGA-3') as described previously (Cho et al.; Iwakuma et 
al., 2005). Non-targeting scrambled siRNA #1 (Dharmacon) was used as a negative 
control. 100 nM of p63-siRNA (Dharmacon) was transfected into tumor cell lines using 
Fugene HD (Roche) following the manufacturer’s protocol. 
 
Adenovirus-Cre infection 
1 X 106 ΔNp63fl/fl keratinocytes were plated on J2-3T3 feeder in 10cm dish and 
infected with 5 X 103 Ad-Cre-GFP (Vector Development Lab, Baylor College of 
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Medicine) particles per cell. The efficiency of infection was calculated by GFP 
expression and rate was about 99%. Western analysis was performed for ΔNp63 to 
verify recombination. 
 
Retroviral infection (pSuper mouse DGCR8-1)  
1 X 106 wild-type keratinocytes were plated on J2-3T3 feeder in 10cm dish and 
infected with pSuper mouse DGCR8-1 (Addgene) as described previously (Su and 
Chakravarti et al., 2010). 
 
Boyden chamber assays for cell migration and invasion. 
Twenty-four hours after transfection, Os-1 and Os-2 cell lines transiently 
expressing p63-siRNA were plated at a density of 2.5 x 104 on a membrane or matrigel 
(BD Biosciences). Migrated or invaded cells were visualized using Diff-Quik stain 
(Sigma). 
 
Skeleton preparation and staining 
Embryos were collected at E18.5. Skin and internal organs were discarded, and 
the remaining embryo was fixed overnight in 95% ethanol at room temperature. The 
following day, the cartilage was stained in 0.05% alcian blue (Sigma) in 95% ethanol in 
acetic acid for 6 hours and then destained in 1% KOH overnight. Bone staining was 
performed in 0.015% alizarin red (Sigma) in 1% KOH. The embryonic skeleton was 
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washed in 20% glycerol in 1% KOH and changed twice per day until the solution was 
clear.  
 
Statistics.  
Data are represented as mean ± SEM. Data were analyzed using a Student’s t test. A p 
value of 0.05 was considered significant. All experiments were done at least in triplicate. 
 
Graph. 
All graphs were plotted with PRISM5 software (GraphPad).  
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Chapter 3.  
New targets of p63 in epithelial development, limb development and metastasis 
 
 
 
 
 
 
 
 
 
Some parts of this chapter were modified from the following journals. 
1. Cho MS, Chan IL and Flores ER. Cell Cycle 9:12, 1-8; June 15, 2010 ΔNp63 
transcriptionally regulates brachyury, a gene with diverse roles in limb development, 
tumorigenesis and metastasis. Reproduced with permission from Cho et al., and 
Copyright clearance center. 
2. Su X, Cho MS, Gi Y, Ayanga BA, Sherr CJ, and Flores ER. EMBO J. 2009 Jul 
8;28(13):1904-15. Rescue of key features of the p63-null epithelial phenotype by 
inactivation of Ink4a and Arf.  Reproduced with permission from Su et al., and 
Copyright clearance center. 
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3.1. The role of p63 as a transcriptional repressor of Arf/Ink4a 
 
Rationale: Deletion of p63 in the mouse results in a generalized loss of stratified 
epithelium due to defects in the maintenance of stem cell proliferative capacity, 
differentiation, and cell-cell adherence (Mills et al., 1999; Senoo et al., 2007; Yang et al., 
1999).  We therefore interbred p63+/- mice with animals lacking either Ink4a or Arf 
(since inhibition of Ink4a-Arf locus is essential for the process of stem cell renewal in 
hematopoietic stem cell) to generate mice lacking both Ink4a and p63 or Arf and p63.  
 
Hypothesis: The formation of stratified epithelium is restored in the compound mutant, 
ArfGFP/GFP;p63-/- and Ink4a-/-;p63-/- mice by rescuing of the proliferative capacity of 
epidermal stem cells and differentiation.   
 
3.1.1. The phenotypic features of p63-/- mice are partially rescued by loss of Arf or 
Ink4a. 
 The p63-/- mice have striking defects in the epidermis, cleft lip and palate, and 
craniofacial abnormalities during embryonic development (Mills et al., 1999; Yang et 
al., 1999). Due to defects in the incomplete stratified epidermis and ectodermal 
malformation that result in desiccation of the newborn and maternal neglect, p63-/- mice 
die after birth.  Others studies suggested that these phenotypes of p63-/- mice were 
because of defects in stem cell proliferative maintenance or incomplete differentiation 
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and cell-cell adhesion (Mills et al., 1999; Yang et al., 1999; Zindy et al., 2003a). 
However there is not yet a clear mechanism, which would explain the defects observed 
in p63-/- developing mice. Recently, repression of both Arf and Ink4a has been 
implicated in stem cell renewal and proliferation (Bracken et al., 2007; Bruggeman et al., 
2005; Molofsky et al., 2005; Molofsky et al., 2003). Arf and Ink4a are known to be 
tumor suppressors. To tease out whether incomplete stratified epidermis results from the 
role of p63 in stem cell renewal, Arf and/or Ink4a mutant mice were generated in p63-/- 
background. The hypothesis is that loss of Arf and/or Ink4a lead to rescue of the p63-/- 
phenotype observed in the incomplete stratified epidermis of the mouse.  To test this 
hypothesis,  p63+/- mice (Yang et al., 1999) were intercrossed with the ArfGFP/GFP(Zindy 
et al., 2003a) and Ink4a-/- (Sharpless et al., 2001) mice to first obtain double 
heterozygous mice (ArfGFP/+;p63+/- and Ink4a+/-;p63+/-). In order to restore stem cell 
renewal potential in the p63-/- mice, sequential matings by intercrossing ArfGFP/+;p63+/- 
and Ink4a+/- ;p63+/- mice gave rise to ArfGFP/GFP;p63-/- and p16Ink4a-/-;p63-/- mice 
respectively.  Pups were born at a Mendelian ratio and ArfGFP/GFP;p63-/- and Ink4a-/-;p63-
/- mice were viable as neonates, however they also died hours after birth as seen in p63-/- 
mice. By macroscopic examination of 10 neonates of each genotype, it was found that 
they were born with skin covering more than 80% of the body, but 10-20% of embryos 
retained craniofacial and limb defects. They died due to maternal neglect within hours 
after birth.  Intriguingly, both double mutant, ArfGFP/GFP;p63-/- and Ink4a-/-;p63-/-, 
embryos at embryonic day E18.5 and newborn mice had a thin single layer of skin 
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covering 85-95% of the body by microscopic examination (Table 1). 20 embryos of 
each ArfGFP/GFP;p63-/- and Ink4a-/-;p63-/-  were analyzed at E18.5.  These embryos had 
dull and opaque skin with partially patched stratified epithelium (Figure 8C & D), 
compared to the shiny and translucent appearance of the p63-/- embryos devoid of such 
epithelium (Figure 8B).  Interestingly, both double mutant embryos exhibited 
elementary limbs and a long tail (Figure 8C & D).  Strikingly, 18 of 20 ArfGFP/GFP;p63-/- 
and 16 of 20 Ink4a-/-;p63-/- had retained the appearance of normal facial features and 
fully developed ears (Figure 8C & D) (Table 1). 
 
3.1.2. Loss of Arf or Ink4a partially rescues the limb defect of the p63-/- mice. 
 There is incomplete limb development in p63-/- mice and because 18 out of 20 
ArfGFP/GFP;p63-/- and 16 out of 20 Ink4a-/-;p63-/- embryos had the appearance of primitive 
limbs, a careful analysis of the skeletal structure was performed (Figure 8E-P) using 
cartilage/bone staining method. The forelimbs of ArfGFP/GFP;p63-/- and Ink4a-/-;p63-/- 
embryos were well developed with scapula, humerus and ulna that were most cases 
similar in size to wild-type embryos (Figure 8I-L) (Table 2).  In addition, in both 
ArfGFP/GFP;p63-/- and Ink4a-/-;p63-/- embryos (Figure 8K & L) immature digits were 
observed whereas the forelimbs were significantly smaller in the p63-/- embryos (Figure 
8J) (Table 2).  As in the ArfGFP/GFP;p63-/- and Ink4a-/-;p63-/- embryos, the pubic bone is 
similar in size to wild-type and fused but still does not completely develop hind limbs. 
The p63-/- embryos do not have well developed hind limbs: (compare Figure 8O & P to 
 51 
Figure 8M) (Table 2).  Additionally this fusion does not occur in the p63-/- mice 
(Figure 8N). Limb development will be discussed in chapter 3.2 and chapter 5.1 
sections in more detail. 
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Figure 8. Macroscopic analysis of embryos at day E18.5. (A–D) Representative 
images of embryos with their respective genotypes indicated above each panel; WT 
indicates wild type. The white arrow in (B) points to cleft lip and palate in p63−/− 
embryo. White arrows in (C, D) designate strings of desquamated epithelium and 
forelimbs. (E–P) Show skeletal preparations from E18.5 embryos stained with Alcian 
Blue for cartilage and alizarin red for bone. Whole embryos (E–H) were of the following 
genotypes: (E), wild type; (F), p63−/−; (G), ArfGFP/GFP;p63−/−; and (H), Ink4a−/−;p63−/−. 
Analysis of forelimbs (I–L) from (I), wild type; (J), p63−/−; (K), ArfGFP/GFP;p63−/−; and 
(L), Ink4a−/−;p63−/− embryos. The arrowheads in (K) and (L) point to rudimentary digits. 
Designated bones include the scapula (s), humerus (h), radius (r), and ulna (u). (M–P) 
Analysis of pubic bones and hind limbs from (M), wild type; (N), p63−/−; (O), 
ArfGFP/GFP;p63−/−; and (P), Ink4a−/−;p63−/− embryos. Designated bones include the ilium 
(il), ischium (is), and pubic bone (p). A 2 mm scale bar is included in the corner of (P). 
Reproduced with permission from Su et al., EMBO J. 2009 July 8; 28(13): 1904-
1915 and Copyright clearance center. 
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3.1.3. Loss of Arf or Ink4a restores the formation of stratified layers of skin in p63-/- 
mice.   
 Macroscopic examination of double mutant embryos showed that they retained 
the appearance of epidermis unlike p63-/- mice skin. We, thus, hypothesized that loss of 
Arf or Ink4a rescues the epidermal defect observed in the p63-/- embryos.  To test the 
extent of epithelial rescue that occurs in double mutant embryos, microscopic analyses 
for epidermal structure and epidermal markers were performed by hematoxylin and 
eosin (H&E) staining and immunofluorescence (IF) for keratin 5 (K5) for basal layer 
markers, keratin 15 (K15) for a hair follicle marker, keratin 10 (K10) for a spinous layer 
marker and filaggrin (Fila) for a granular layer marker (Figure 9; Table 1).  The H&E-
stained sections of embryonic day E18.5 ArfGFP/GFP;p63-/- embryos revealed a well-
layered basal layer of epithelium surrounding the embryo (Figure 9C).  Twenty 
ArfGFP/GFP;p63-/-  embryos had an average coverage of 85% by H&E staining.  The extent 
of rescue in the 20 Ink4a-/-;p63-/- embryos examined was even more striking with the 
appearance of structures that resembled hair follicles (Figure 9D; Table 1).  10±2 hair 
follicles per centimeter were apparent in all 20 of the Ink4a-/-;p63-/- embryos compared to 
64±4/cm in the wild-type and 0/cm in the ArfGFP/GFP;p63-/- and p63-/- mice (Table 1).  To 
further analyze the structure of the epithelium in order to determine whether there is a 
rescue in Ink4a-/-;p63-/- and ArfGFP/GFP;p63-/- embryos, IF was performed using K5 and 
K14, markers of the basal layer, K10, a marker of the spinous layer, and Fila, a marker 
of the granular layer of the epithelium. To determine whether the cell adhesion defect is 
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rescued in Ink4a-/-;p63-/- and ArfGFP/GFP;p63-/- embryos, IF was also performed using 
antibodies: collagen IV for the basement membrane and E-cadherin for cell adhesion. 
These epidermal layer markers were completely absent or stained feebly in the p63-/- 
embryos (Mills et al., 1999; Yang et al., 1999). Consistent with previously published 
data (Mills et al., 1999; Yang et al., 1999), 3 of the 20 p63-/- embryos had an average of 
2% K5 positive cells in patches on the area above the dermis (Figure 9F; Table 1).  K5 
staining in the ArfGFP/GFP;p63-/- and Ink4a-/-;p63-/- mice stained encircle the embryos 
(Figure 9G & H; Table 1) indicating the presence of a stratified multilayer basale.  
More remarkably, K10 staining was apparent and stained around the embryos (Figure 
9K & L; Table 1).  Strikingly, in the Ink4a-/-;p63-/-, the appearance of a multilayer 
stratified epithelium, which stained positive for K5, K10 and Fila (Figure 9G, H, K, L, 
O & P), was more apparent and evidence of hair follicle-like structures staining 
positively for K15 was also visible (Figure 9) (Liu et al., 2003b) . K15 staining 
indicated the presence of epidermal precursor cells in double mutant embryos (Figure 
9S & T).  
We also determined whether loss of p53 rescued the p63-/- phenotype. We 
analyzed twenty p53-/-;p63-/- embryos at embryonic day E18.5. Seventy percent (14 of 
20) of p53-/-;p63-/- embryos died in utero at embryonic day E15.5 (Sah et al, 1995). 
However viable embryos at embryonic day E18.5 had a similar phenotype as p63-/- 
embryos (Table 1) indicating that the rescue of the p63-null phenotype by loss of the 
Ink4a-Arf locus is independent of the p53 pathway. 
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Figure 9. Microscopic analysis of the epithelium of embryos at E18.5. Cross sections 
of skin stained with hematoxylin and eosin (A–D) and immunofluorescence using 
antibodies to keratin 5 (red) (E–H), keratin 10 (red) (I–L), filaggrin (red) (M–P), and 
keratin 15 (green) (Q–T) and counterstained with DAPI (blue) are illustrated. The 
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genotypes for each vertical set of panels are indicated at the top of the figure. Broken 
lines define the border between the dermis and epidermis. Reproduced with permission 
from Su et al., EMBO J. 2009 July 8; 28(13): 1904-1915.  
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Table 1. Quantification of epithelial structures in day 18.5 embryos 
Genotype # of embryo K5 K10 Fila 
Embryo 
w/ hair 
follicle 
Embryo 
w/ cleft 
palate 
Embryo 
w/fore-
limbs 
WT 20 100% 100% 100% 20 0 20 
p63-/- 20 2% 5% 0% 0 20 3 
ArfG/G;p63-/- 20 85% 75% 50% 0 4 18 
Ink4a-/-;p63-/- 20 85% 85% 75% 20 2 20 
p53-/-;p63-/- 6* 0% 0% 0% 0 6 0 
 
Shown are the numbers of embryos analyzed per genotype. Numbers in columns with % 
represent the mean from 20 embryos analyzed per group. The asterisk (*) indicates that 
only 6 of 20 p53-/-;p63-/-! embryos could be analyzed at E18.5; the remaining 14 
embryos died in utero at day 15.5. 
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3.1.4. Proliferation of p63-/- keratinocytes is restored in the absence of Arf or Ink4a. 
   Extraction of keratinocytes from p63-/- mice is difficult because of the defect in 
complete formation of stratum epithelia of the p63-/- mice. Consistent with previously 
published data, cells could be extracted from the surface of p63-/- and also p63-/-;p53-/- 
embryos; however, they do not proliferate on J2-3T3 feeder cells (Figure 10) 
(Barrandon and Green, 1987). Arf and Ink4a are known to be repressors of stem cell self-
renewal (Molofsky et al., 2005; Molofsky et al., 2003). To determine whether loss of Arf 
or Ink4a could restore the proliferation defect of the p63-/- keratinocytes, the epidermal 
cells were isolated from ArfGFP/GFP;p63-/- and Ink4a -/-;p63-/- embryos at embryonic day 
E18.5 (Figure 10). These keratinocytes were cultured on J2-3T3 feeder cells to maintain 
stem cell properties (Barrandon&Green 1987; Flores et al., 2000).  Excitingly, double 
mutant keratinocytes formed colonies similar to those formed by wild-type keratinocytes 
(Figure 10A-E).  However, ArfGFP/GFP;p63-/- and Ink4a-/-;p63-/- keratinocytes did not 
form condensed colonies due to the lack of adhesion to each other (Figure 10C, E, H, 
and J). These cells were stained with K5, a marker of the stratum basale (Figure 10F-
J).  Both the ArfGFP/GFP;p63-/- and Ink4a-/-;p63-/- keratinocytes express K5 indicating that 
the isolated cells originated from keratinocytes.  The fact that the ArfGFP/GFP;p63-/- and 
Ink4a -/-;p63-/- keratinocytes were less adherent to each other is not surprising given that 
p63 has also been shown to regulate genes involved in cell adhesion (Carroll et al., 2006; 
Ihrie et al., 2005). This data is consistent with the macroscopic appearance of 
ArfGFP/GFP;p63-/- and Ink4a -/-;p63-/- mice, which have fragile skin. 
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 To further understand the extent of rescue of the proliferation defect of p63-/- 
keratinocytes by loss of Arf or Ink4a, keratinocytes were cultured on J2-3T3 feeder cells 
(Barrandon and Green, 1987; Flores et al, 2000).  Beginning at passage 2, wild-type, 
p63-/-, ArfGFP/GFP, Ink4a-/-, ArfGFP/GFP;p63-/-, and Ink4a-/-;p63-/- keratinocytes were 
monitored and counted every day for 8 days.  While the p63-/- keratinocytes did not 
proliferate, cells of all other genotypes (wild-type, ArfGFP/GFP, Ink4a-/-, ArfGFP/GFP;p63-/-, 
and Ink4a-/-;p63-/-) continued to proliferate over the 8-day time course (Figure 10K).  
The most proliferative keratinocyte lines were the Ink4a-/- and ArfGFP/GFP while the 
ArfGFP/GFP;p63-/-, and Ink4a-/-;p63-/- keratinocytes were as proliferative as wild-type 
keratinocytes.  Additionally, these cells were passaged 7 times every 5 days and the 
accumulated population doublings were assessed (Figure 10L).  The p63-/- keratinocytes 
senesced at passage 1, however all other genotypes continued to proliferate in later 
passages.  The wild-type keratinocytes senesced at passage 3, while the Ink4a-/-, 
ArfGFP/GFP, Ink4a-/-;p63-/-, and ArfGFP/GFP;p63-/-  keratinocytes reached 12 to 14 
accumulated population doublings by passage 7 (Figure 10L).  p53-/-;p63-/- keratinocytes 
also senesced at passage1 comparable to p63-/- keratinocytes (Figure 10K-L). This data 
suggested that the proliferation defect in the p63-/- keratinocytes cannot be rescued by the 
loss of p53, however it was dependent on loss of the Ink4a-Arf locus. 
 
 60 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 61 
Figure 10.	   Keratinocyte cultures derived from embryos at E18.5. (A–E) Light 
micrographs of keratinocytes cultured on J2-3T3 feeder cells with their respective 
genotypes indicated to the left of the panels. Black arrows indicate the positions of 
keratinocytes colonies. (F–J) Immunofluorescence obtained with an antibody to keratin 
5 (red), a marker of basal epithelial cells; cells were counterstained with DAPI (blue). 
(K) Indicates the proliferation rates of cultured keratinocytes of the following genotypes: 
wild type (WT, blue), ArfGFP/GFP (Arf, red), Ink4a-/- (Ink4a, yellow), p63-/- (p63, green), 
p53-/-;p63-/- (brown), ArfGFP/GFP;p63-/- (Arf;p63, purple), and Ink4a-/-;p63-/- (Ink4a;p63, 
orange). (L) Computes the cumulative population doublings of keratinocytes cultures 
passaged every 5 days for seven passages. The average of results obtained with three 
independent keratinocytes lines each assayed in triplicate is shown. The genotypes are 
indicated as in (K). Reproduced with permission from Su et al., EMBO J. 2009 July 
8; 28(13): 1904-1915.  
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3.1.5. p63 represses p19Arf and p16Ink4a leading to proper proliferation and 
differentiation. 
 The failure to generate proliferative keratinocytes from p63-/- mice, together with 
the rescue of this process in Arf null and Ink4a-null backgrounds strongly suggested that 
p63 negatively regulates Arf and Ink4a expression. p19Arf knock out mice used a GFP 
reporter knock in strategy (Zindy et al., 2003a). To understand further whether the 
untimely expression of Arf and Ink4a proteins in the absence of p63 can inhibit the 
outgrowth of keratinocytes leading to the profound defects in epidermal development.  
To test this hypothesis, the GFP reporter gene was used to detect whether there is 
any differential expression in ArfGFP/GFP and ArfGFP/GFP;p63-/- cells, since Arf is not 
detectable during normal mouse epithelial development (Zindy et al., 2003b).  
Interestingly, GFP levels were 2.5 fold higher in MEFs and 3 fold higher in 
keratinocytes in the absence of p63 providing further evidence that p63 represses Arf 
expression (Figure 11C & D).  The difference in GFP levels between ArfGFP/GFP and 
ArfGFP/GFP;p63-/-  keratinocytes was also detected by immunofluorescence (Figure 11E 
& F).  Remarkably, GFP levels were also found to be higher in vivo in the epithelium of 
ArfGFP/GFP;p63-/- compared to ArfGFP/GFP embryos at embryonic day E18.5 suggesting that 
this repression of p19Arf is necessary for the complete formation of epidermis of p63-/- 
mice (Figure 11A-F). Interestingly, western blot analysis also revealed that p19Arf 
expression is higher in p63-/- MEFs and keratinocytes than in their wild-type 
counterparts indicating that p63 represses expression of p19Arf (Figure 11G & H). To 
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further verify whether the repression of p63 affects levels of Arf and Ink4a transcripts, q-
RT PCR was performed (Figure 11J & K).  Arf RNA levels were increased 15 fold in 
the absence of p63 and likewise, the levels of p16Ink4a were slightly increased in the 
absence of p63 suggesting that p63 transcriptionally represses p16Ink4a and p19Arf 
(Figure 11J & K).  
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Table 2. Quantification of length of limbs in day 18.5 embryos 
 
Shown is the mean (±s.d.) measured in mm of the indicated skeletal structures. 
Measurements were taken from 10 embryos per genotype. 
 
 
 
 
 
 
 
 
Genotype Scapula Humerus Ulna Pubic bone 
WT 4.8±0.2 4.4±0.1 4.8±0.2 3.9±0.3 
p63-/- 3.8±0.1 0.5±0.1 1.5±0.2 2.6±0.1 
ArfG/G;p63-/- 5.0±0.1 1.5±0.2 2.8±0.3 3.9±0.1 
Ink4a-/-;p63-/- 5.0±0.1 2.8±0.3 4.5±0.3 3.9±0.2 
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Figure 11. Expression of p19Arf, p16Ink4a, and GFP in keratinocytes and stratified 
epithelium. (A–C) GFP expression in keratinocytes of the indicated genotypes (top). 
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Cells were counterstained with DAPI (blue). Representative colonies of cultured 
ArfGFP/GFP;p63-/- keratinocytes (B, C) were vividly fluorescent when compared (matched 
exposures) with cultures at the same passage derived from ArfGFP/GFP;p63+/+ mice (A). 
(D–F) Cross sections of stratified epithelium from E18.5 embryos stained with 
antibodies to GFP (red). DAPI (blue) was used as a counterstain. The respective 
genotypes correspond to those indicated above (A–C). Matched exposures are shown. 
(G, H) Immunoblotting analysis of selected proteins (indicated at the left) identified in 
detergent lysates of age-matched passage-2 keratinocytes (B) of the indicated genotypes 
(top). Passage-2 p53-/- MEFs were used as a positive control (G). Actin was used as a 
loading control. (I–K) q-RT PCR of the indicated mRNAs (top) extracted from E18.5 
dermis/epidermis of the indicated genotypes (bottom). GAPDH was used as an internal 
control. Reproduced with permission from Su et al., EMBO J. 2009 July 8; 28(13): 
1904-1915.  
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3.1.6. The Arf and Ink4a transcripts were repressed by restoration of p63 in double 
mutant MEFs. 
 Because expression of Arf RNA and protein was high in p63-/- MEFs, to further 
understand whether there is repression of Arf and Ink4a by p63, p63 isoform specific 
plasmids were transfected into p63-/- or ArfGFP/GFP;p63-/-  MEFs. Q-RT PCR was 
performed to determine whether p63 restoration affects levels of Arf and Ink4a mRNA 
transcription (Figure 12A & B).  Arf and Ink4a RNA levels were diminished in the 
presence of p63 and GFP levels were slightly decreased in the presence of p63 
suggesting that Arf and Ink4a are transcriptionally repressed by p63 restoration (Figure 
12A & B). The Flores laboratory showed that p63 directly binds to the promoters of Arf 
and Ink4a to repress transcription of the genes (Su et al., 2009). Taken together, these 
data suggest that p63 plays a role as a transcriptional repressor of Ink4a and Arf and the 
repression of Ink4a and Arf  is necessary for epithelialization. 
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Figure 12. p63 represses Arf and Ink4a.  
(A, B & C) q-RT PCR of the indicated mRNAs (top) extracted from the specified MEFs 
transfected with the indicated expression vectors (bottom). GAPDH was used as an 
internal control. The asterisk denotes statistical significance (P < 0.01). Reproduced 
and modified with permission from Su et al., EMBO J. 2009 July 8; 28(13): 1904-
1915.  
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3.2. The role of p63 as a transcriptional activator of Brachyury 
Rationale: Human patients with dominantly inherited point mutations of p63 in the 
DNA binding domain or SAM domain develop ectodermal dysplasias, including 
ectrodactyly (Celli et al., 1999; McGrath et al., 2001); however, the underlying 
mechanism is not yet well understood.  Mice deficient for p63 display similar defects to 
those seen in humans and mice in the malformation of ectodermal appendages and 
epithelial tissues (Mills et al., 1999; Yang et al., 1999). The Flores laboratory’s previous 
genome-wide analysis identified brachyury as a putative transcriptional target of p63 
(Lin et al., 2009). The p63 mutant mice display multiple defects including failure of 
proper limb formation and as well as tumor formation in heterozygous mice (Flores, 
2007; Flores et al., 2005; Mills et al., 1999; Yang et al., 1999). Mice mutant for both p63 
and p53 (p53+/-;p63+/-) develop metastatic tumors at high frequency (Flores et al., 2005). 
 
Hypothesis: p63 regulates brachyury, which is critical for appropriate limb formation, 
tumorigenesis, and metastasis.  
 
3.2.1. Brachyury gene expression is down regulated in the absence of p63 
Mice in the absence of p63 have truncated or absent limbs (Mills et al., 1999; 
Yang et al., 1999). However the roles of p63 in limb development have not been well 
elucidated. Our laboratory has reported recently that many genes were down regulated in 
the absence of p63 by genome wide screening using a 15,000cDNA microarray, and the 
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brachyury was one of the downregulated genes in p63-/- MEFs (Lin et al., 2009). 
Brachyury is an important gene playing diverse roles in the apical ectodermal ridge 
(AER) formation during limb development (Liu et al., 2003a) and contributing to tumor 
metastasis (Palena et al., 2007; Yang et al., 2009). During development, in early 
embryonic stages, brachyury mRNA is expressed from E5.5 to E12.5 and interestingly, 
p63 mRNA is also highly expressed at the AER at embryonic day E10.5 within the 
window of AER formation (Lo Iacono and Gross, 2008) in the developing mouse 
embryo (Inman and Downs, 2006; Wilkinson et al., 1990), leading to the hypothesis that 
p63 plays a role in regulating brachyury gene expression during limb development.  
Interestingly, we found that brachyury gene expression pattern is similar to the 
expression pattern of ΔNp63 mRNA during wild-type mouse embryo development 
(Figure 13A & B).  To determine whether brachyury expression is down regulated in 
the developing p63-/- embryo, RNA was isolated from wild type and p63-/- whole 
embryos at embryonic day E9.5, when AER formation takes place and brachyury 
mRNA highly expressed in the AER (Liu et al., 2003). q-RT PCR was performed using 
brachyury primers, brachyury expression was found to be 7.5 fold lower in p63-/- 
compared to wild-type embryos (p < 0.01, Figure 13A), indicating that p63 probably 
transcriptionally regulates brachyury expression since p63 is a transcription factor (Yang 
et al., 1998). 
The Flores laboratory has shown recently that mice develop normal limbs in the 
absence of TAp63 (Su et al., 2009), leading us to hypothesize that the ΔNp63 isoforms 
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are essential for proper limb development.  First, to ask whether brachyury expression is 
downregulated in TAp63-/- whole embryos, wild type and TAp63-/- embryos were 
generated at embryonic day E9.5 and q-RT PCR for brachyury was performed using 
RNA from wild type and TAp63-/- embryos.  As expected, expression of brachyury was 
comparable to the wild-type levels in TAp63-/- embryos (Figure 13B), indicating that 
ΔNp63, and not TAp63, regulates brachyury gene expression within a window of 
embryonic limb development. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 72 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Brachyury is downregulated in the absence of p63. Quantitative RT-PCR 
(q-RT PCR) for (A) ∆Np63 or (B) brachyury in wild-type embryos at 9.5, 13.5 and 18.5 
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days post coitum (dpc). (C) q-RT PCR for brachyury in wild-type (Wt), p63 deficient 
(p63-/-) and TAp63 deficient (TAp63-/-) embryos at day 9.5 dpc. Fold change relative to 
wild-type levels of ΔNp63 or brachyury mRNA is shown on the y-axis for each 
genotype on the x-axis each bar represents the average of three independent experiments. 
The asterisk indicates statistical significance (p-value <0.01). Reproduced with 
permission from Cho et al., Cell Cycle 9:12, 1-8; June 15, 2010 
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3.2.2. p63 binds to the promoter of brachyury.  
As a transcription factor, p63, like p53, has been known to bind to a consensus 
sequence of the promoter and transcriptionally regulates its target genes. The consensus 
binding site is PuPuPuC(A/T)(T/A)GPyPyPy - 0-13bp spacer - 
PuPuPuC(A/T)(T/A)GPyPyPy (Lin et al., 2009 Flores et al., 2002). By following this 
rule, Dr. Flores identified a putative p53/p63 consensus site 138 nucleotides upstream of 
exon 1 (-138 site) (Figure 14A).  This site, actCTTGtcgcgcCTTGcgg, that follows the 
rule of p53/p63 consensus site with some base pair mismatches (Lin et al., 2009; Flores 
et al., 2002).  To determine whether p63 can bind to this putative consensus site on the 
promoter of brachyury, chromatin immunoprecipitation (ChIP) assay was performed 
using nuclear extracts from wild type and p63-/- mouse embryonic fibroblasts (MEFs) 
derived from embryonic day E13.5 embryos.  Using two different antibodies for p63, 
ChIP analysis from wild type MEFs demonstrated that p63 binds to the -138 site of the 
brachyury promoter (Figure 14B).   
All p53 family members, p53, p63 and p73, share some target genes consensus 
sites and all p53 family members are predicted to bind to this identified consensus site 
(Flores et al., 2002). To determine if p53 and p73 can also bind to the brachyury 
promoter, ChIP analysis was performed using antibodies for p53 and p73 in wild type, 
p63-/- and p53-/- MEFs.  Although these family members bound to the p21 promoter 
(Figure 14C), which is a representative target gene of p53, but the binding of p53 and 
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p73 was not detected to this -138 site of brachyury promoter indicating that p63 is the 
only family member of p53 that binds to the brachyury promoter (Figure 14B).  
 Previously, the Flores laboratory has reported that p53, p63 and p73, have 
interdependent binding at some promoter sites (Lin et al., 2009). To figure out whether 
p63 binding to brachyury promoter is impaired in the absence of p53, ChIP analysis was 
performed using antibodies for p63 from wild type, p53-/-, and p63-/- MEFs.  Indeed, p63 
binding to the -138 sites was not dampened in the absence of p53, suggesting that p63 
does not require the presence of p53 to bind to the brachyury promoter and clearly 
showing that the only p53 family member who regulates transcription of brachyury is 
p63. 
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Figure 14. p63 binds to the brachyury promoter. (A) Schematic of the promoter of 
brachyury including the sequence of the p53/p63-binding site located 138 nucleotides 
upstream of the start site. Mismatches are shown in red. (B) ChIP analysis of wild-type 
(WT), p63-/-, and p53-/- mouse embryonic fibroblasts (MEFs) using antibodies against 
p53, p63 or p73. PCR was performed using primers flanking the p63 binding site and an 
upstream non- specific site (NS) shown in (A). (C) ChIP analysis of the p21 promoter 
using antibodies for p53, p63 and p73. Total input chromatin for each PCR ChIP 
reaction is shown. ChIP experiments were performed on 3 MEF lines of each genotype 
in triplicate. Reproduced with permission from Cho et al., Cell Cycle 9:12, 1-8; June 
15, 2010 
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3.2.3. ΔNp63α  and β  transcriptionally activate brachyury.  
To further understand whether p63 physically binds to the promoter of brachyury 
that turns on gene transcription, a luciferase reporter gene assay was performed using a 
p63 consensus site from the brachyury promoter (-138 site). Two brachyury promoter 
luciferase reporter constructs were generated: brach1 and brach2.  Brach1 contained the 
5’ upstream region of the transcriptional start site, including the p63 consensus element, 
and Brach 2 contained the sequence of Brach1, exon1 and intron 1 of brachyury (Figure 
15A). To know which isoforms of p63 bind and turn on gene transcription, TAp63 (α, β, 
γ) or ΔNp63 (α, β, γ) isoforms expressing plasmids were transfected with brach1 or 
brach2 into p53-/-;p63-/- (MEFs). Consistent with q-RT PCR result (Figure 13), we found 
that ΔNp63α and β were the only isoforms that transactivated both the brach1 and 
brach2 luciferase reporter gene activity (Figure 15B) indicating only ΔNp63α and β 
isoforms transactivate brachyury gene promoter. The TAp63 isoforms do not have this 
activity, consistent with the phenotype of the TAp63-/- mice, which show no limb 
development defect (Su et al., 2009). To further confirm whether the p63 consensus site 
was specific for the transactivation activity on the brachyury promoter in the luciferase 
assay, the construct was mutated with the minimal site necessary for brachyury 
transactivation by p63 (Brach1). The mutant construct, named as Brach 1m, includes two 
point mutations in the half sites required for p63 binding (Figure 15A). Using Brach 1m 
in the luciferase assays, transactivation by the p63 isoforms was not detected indicating 
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that the identified p63 consensus site is specific for brachyury transactivation (Figure 
15B). 
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Figure 15. Brachyury is transactivated by ∆Np63α and ∆Np63β. (A) Schematic 
structure of brachyury luciferase gene reporter constructs, Brach1, Brach2 and Brach1m. 
(B) Bar graph showing luciferase assay in p53-/-;p63-/- MEFs transfected with the 
indicated p63 isoform expressing plasmids and the indicated luciferase reporter gene. 
Each bar represents the average of the fold activation of three independent experiments. 
The asterisks indicate statistical significance (p-value <0.01). Reproduced with 
permission from Cho et al., Cell Cycle 9:12, 1-8; June 15, 2010 
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3.2.4. The level of brachyury expression correlates with the level of ΔNp63 
expression in osteosarcoma cell lines 
Brachyury plays diverse roles during development and is also highly expressed in 
several human cancers (Palena et al., 2007; Vujovic et al., 2006; Yang et al., 2009). 
Indeed, ΔNp63 has also been suggested to play oncogenic roles since it is highly 
expressed in many human cancers (Cox et al., 2009; Flores, 2007). To determine 
whether ΔNp63 expression correlates with brachyury expression in tumors, q-RT PCR 
was performed using tumor cell lines from p53+/- and p53+/-;p63+/- mice. They expressed 
various level of ΔNp63 (Figure 16A). To tease out whether TAp63 and ΔNp63 
differentially correlate with brachyury expression in these tumor cell lines, q-RT PCR 
was performed using primers for TAp63, ΔNp63, and brachyury from total RNA derived 
from cell lines of 1 rhabdomyosarcoma (RS), 3 osteosarcomas (Os-1, Os-2 and Os-3), 1 
mammary adenocarcinoma (MAd), and 1 lung adenocarcinoma (LAd).  By q-RT PCR, 
all tumor cell lines showed low levels of TAp63 expression (Figure 16A).  Interestingly, 
two of 3 osteosarcoma cell lines (Os-1 and Os-2) expressed high levels of ΔNp63 and 
those concomitantly expressed high levels of brachyury (Figure 13A).  As expected, 
other cell lines with low levels of ΔNp63 also expressed low levels of brachyury, 
indicating that the expression of these two mRNA transcripts does indeed have some 
correlation. 
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Figure 16. ∆Np63 expression induces brachyury in tumor cell lines. (A) q-RT PCR 
using total RNA from the indicated tumor cell lines for TAp63, ∆Np63 and brachyury. 
(B) q-RT PCR and (C) Western blot analysis for expression of ∆Np63 in Os-1 and Os-2 
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osteosarcoma cells transfected with scrambled (sc) or p63 siRNA (p63). (D) q-RT PCR 
of brachyury mRNA in Os-1 and Os-2 cells after transfection with scrambled (sc) or p63 
siRNA (p63). (E and F) q-RT PCR for (E) ∆Np63 and (F) brachyury in Os-3 
osteosarcoma cell lines transfected with ∆Np63α and ∆Np63β. each experiment was 
performed in triplicate. the asterisks indicate statistical significance (pvalue <0.01). 
Reproduced with permission from Cho et al., Cell Cycle 9:12, 1-8; June 15, 2010 
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3.2.5. Loss of ΔNp63 results in concomitant downregulation of brachyury expression 
 To further explain the correlations between ΔNp63 and brachyury expression, 
levels of ΔNp63 were knocked down using a siRNA approach. Specifically, siRNA was 
used for p63, targeted to the DNA binding domain of p63, (Iwakuma et al., 2005) and it 
was transfected into two osteosarcoma cell lines (Os-1 and Os-2).  Scrambled siRNA 
(sc-siRNA) was used as a control (Figure 16 B- D).   As expected, knock down p63 
(Figure 16B & C) led to the knock down of ΔNp63.  Transfection efficiency from both 
cell lines with the si-p63 exhibited at least an 80~ 90% knockdown of ΔNp63 (Figure 
16B & C).  To detect whether ΔNp63 knock down resulted in a concomitant decrease in 
brachyury expression, q-RT PCR was performed in these cells and brachyury expression 
was seen to be dramatically decreased (greater than 98%) in both Os-1 and Os-2 cell 
lines compared to the scrambled siRNA (sc-siRNA) transfected cell lines (Figure 16D).  
Additionally, ΔNp63α or ΔNp63β  were overexpressed in Os-3 cells which expressed 
low levels of ΔNp63 and brachyury. Endogenous brachyury expression was restored 
with high levels of ΔNp63α and ΔNp63β (Figure 16E & F). Taken together, these 
results further support that ΔNp63 regulates brachyury expression. 
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3.2.6. Downregulation of p63 leads to loss of brachyury expression and a decrease in 
cell proliferation, migration and invasion 
 Previously, it has been shown that brachyury expression is high in tumors and 
tumor cell lines, which also exhibit increased proliferation.  To determine whether 
knockdown of ΔNp63 with a concomitant downregulation of brachyury has a 
consequence on cellular proliferation, bromo-deoxyuridine (BrdU) incorporation assay 
was performed to measure the percentage of S-phase cells. This assay was performed in 
the osteosarcoma cell lines, Os-1 and Os-2, which have high ΔNp63 and brachyury 
expression. These cells were transfected with siRNA-p63 or scrambled (sc) as a control. 
This transfection with siRNA specific for p63, resulted in greater than 90% knockdown 
of ΔNp63 and a diminution in brachyury expression (Figure 16B & D), the number of 
cells incorporating BrdU was lower compared to cells transfected with a scrambled 
siRNA (Figure 17A).  The percentage of BrdU positive Os-1 cells was initially 79% and 
diminished to 60% after transfection with the siRNA-p63.  Likewise, the level of BrdU 
positivity in Os-2 cells decreased from 64% to 52% after transfection with the si-p63 
(Figure 17B).  The level of BrdU positivity did not change in the cells treated with 
scrambled siRNA (sc-siRNA).  These data imply that loss of ΔNp63 results in lower 
expression of brachyury and fewer proliferative cells. Metastatic tumor cells are highly 
migrative and invasive (Friedl and Wolf, 2003). To determine whether the migration and 
invasion characteristics are altered in these cells, Boyden chamber assay was used to 
measure migration and invasion. Indeed, Os-1 and Os-2 cells with down regulated 
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ΔNp63 and brachyury had a diminished capacity to migrate and invade (Figure 17C & 
D). Taken together, these data suggest that the high expression of ΔNp63 detected in 
many human cancers is critical for upregulation of brachyury and increased cell 
proliferation, migration and invasion in cancer cell lines. Overall, my data suggests that 
ΔNp63 controls limb development via transcripitionally activating brachyury, and in 
tumor, ΔNp63 also regulates cell proliferation, migration and invasion through 
brachyury gene activation. 
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Figure 17. Knockdown of ∆Np63 results in decreased cell proliferation, migration 
and invasion. (A) BrdU positive (green) os-1 and os-2 cells transfected with scrambled 
siRNA (sc) or p63-siRNA (p63). DApI (blue) was used as a nuclear counterstain. (B) 
Bar graph showing the percentage of BrdU positive cells after transfection with 
scrambled (sc) or p63-siRNA. Bar graphs showing (C) the number of cells migrated in a 
Boyden chamber assay and (D) the percentage of cells that have invaded through 
Matrigel in this assay. The asterisks indicate statistical significance (pvalue <0.01). 
Reproduced with permission from Cho et al., Cell Cycle 9:12, 1-8; June 15, 2010 
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Chapter 4.  
ΔNp63 induces terminal differentiation of the epidermis  
through transcriptional regulation of DGCR8. 
 
 
 
 
 
 
 
 
 
 
 
 
Some parts of this chapter were modified from the following manuscript. 
 
1. Min Soon Cho, Xiaohua Su, Deepavali Chakravarti, Arianexys Aquino, Nicole 
Müller, Avinashnarayan Venkatanarayan, Io Long Chan, Young Jin Gi, & Elsa R. 
Flores. ΔNp63 induces terminal differentiation through transcriptional regulation of 
DGCR8 and suppression of pluripotency factors. 
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Chapter 4. The roles of ΔNp63 in epithelial development 
 
Rationale: The phenotypes of the ΔNp63cKO (K14Cre) and the ΔNp63 null are 
reminiscent of the DGCR8 (a microprocessor for microRNAs) conditional knockout 
(cKO) mice and knock out embryonic stem cells (ESCs).  Specifically, these mice 
display a hair follicle outgrowth skin phenotype (Yi et al., 2006; Yi et al., 2009) as 
detected in the ΔNp63+/- mice.  Importantly, DGCR8-/- ESCs display a hyperproliferation 
phenotype and failure of silencing pluripotency genes (Suh et al.; Wang et al., 2007) 
which results in differentiation defects. Interestingly, I have observed that ΔNp63 
deficient epidermal cells display phenotypic characteristics that resemble embryonic 
stem cells instead of keratinocytes. 
 
Hypothesis: ΔNp63 induces terminal differentiation of the epidermis through the 
regulation of DGCR8. 
 
4.1. Generation of ΔNp63 conditional knockout mice 
To understand the role of ΔNp63 in skin development, a ΔNp63−/− mouse was 
generated by intercrossing the ΔNp63 conditional knock out mice (ΔNp63fn/fn) to 
FLPeR transgenic mice (Farley et al., 2000) to eliminate the intervening neo cassette 
(ΔNp63fl/fl) (Figure 18C) and tissue-specific deletion of the ΔNp63 isoforms using the 
cre-loxP system with the retention of the TAp63 isoforms. LoxP sites were inserted into 
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the p63 gene flanking exon 3’, which contains the unique translational start site of the 
ΔNp63 isoforms, to generate a floxed allele (ΔNp63fl) (Figure 18A). Properly targeted 
embryonic stem cells (ESCs) were injected into 129/B6 hybrid donor blastocysts and 
subsequently into pseudo pregnant females. The resulting male chimeras (founder) were 
intercrossed with albino C57/B6 females for germ line transmission detected by 
Southern blot analysis and genotyping PCR (Figure 18B & C). 
To further understand the role of ΔNp63 in skin epithelial development, 
ΔNp63−/− mice were generated by intercrossing the ΔNp63fl mouse (ΔNp63fl/fl) with 
germ line-specific Cre-transgenic mice (Zp3-cre specific for the egg) (Lewandoski et al., 
1997) and resulting ΔNp63+/- male and female were intercrossed to generate ΔNp63−/−. 
Pups died within a few hours after birth due to postnatal desiccation. Q-RT PCR 
performed on timed embryos (9.5 and 18.5dpc) isolated from ΔNp63−/− embryos 
confirmed absence of ΔNp63 mRNA (p < 0.0001) (Figure 18D) or protein expression  
(Figure 18E) with retention of TAp63 mRNA as wild-type levels (Figure 18F) 
throughout embryonic development. 
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Figure 18. Generation of ΔNp63fl/fl conditional knockout and ΔNp63-/- knock out 
mice. 
A) The ΔNp63 targeting vector was generated by inserting loxP sites (triangles) flanking 
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exon 3’ and a neomycin cassette (neo) flanked by frt sites (squares). Location of primers 
used for genotyping is indicated by arrows. The targeted region of the allele is depicted 
by a dashed yellow line. Flox neo (fn) mice were crossed to the FLPeR mice expressing 
the flp recombinase to delete the neo cassette in vivo and to generate the flox (fl) allele. 
The knock out (KO) allele is shown after cre recombination. B) Southern analysis of 
genomic DNA from: ΔNp63fn/+, ΔNp63fn/fn, ΔNp63+/+ and ΔNp63-/- mice. C) PCR 
analysis of genomic DNA from: ΔNp63fl/+, ΔNp63fl/fl, ΔNp63+/+ and ΔNp63-/- mice. 
D) Q RT PCR analysis of ΔNp63 mRNA from E9.5 and E18.5 wild-type and ΔNp63-/- 
embryos. E) Western blot analysis for ΔNp63 using epidermal cells derived from wild-
type and ΔNp63-/- embryos (E18.5) (left panel) and p53-/-;p63-/- MEFs expressing 
ΔNp63α and ΔNp63β cDNAs. Actin was used as a loading control. F) Q RT PCR 
analysis of TAp63 mRNA from E9.5 and E18.5 wild-type and ΔNp63-/- embryos. Q RT 
PCR values are normalized to GAPDH. Asterisks indicate statistical significance, 
(p<0.001). 
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4.2. ΔNp63 knock out mice have a uniform layer of skin but still have a defect in cell 
adhesion 
ΔNp63-/- pups were born but died within hours as a result of a fragile skin that 
could not retain body fluid. Pups still had defects in craniofacial and limb development 
that resulted in lacking nutrition that resulted in maternal neglect (Figure 19A-D). To 
further analyze of ΔNp63-/- phenotypic characteristics, E18.5 embryos were used. 
Interestingly, microscopic analyses highlighted the phenotypic differences between the 
ΔNp63-/- and p63-/- animal skin (Figure 19A-D). The ΔNp63-/- animals have greater 
epidermal development and even hair follicle like structures are observed (Figure 19G).  
To confirm the deletion of ΔNp63 in the epidermal skin, immunohistochemistry 
(IHC) was performed using an antibody against ΔNp63 on sections of embryos. Animals 
from different genotypes, which include the wild type, p63-/-, ΔNp63+/- and ΔNp63-/-.  
ΔNp63 signals are not observed from ΔNp63-/- and p63-/- skin (Figure 19I-L).  
 
4.3. ΔNp63+/- mice have wrinkled and expanded basal layer of skin 
Skin from heterozygote embryos, ΔNp63+/-, macroscopically looked thicker 
compared to the wild type, which led me to question whether there are any phenotypic 
differences in heterozygote skin (Figure 19B). To further analyze the thicker skin 
phenotype from heterozygote embryos, skin from ΔNp63+/- embryos was fixed, paraffin 
embedded, sectioned and stained with hematoxylin and eosin (H&E) (Figure 19F) to 
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observe epidermal architectural differences. Interestingly, the skin from ΔNp63+/- mice 
had expanded and more enucleated cells in the basal layer of epidermis compared to 
wild-type animals.  
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Figure 19. ΔNp63 mutant mice exhibit epidermal abnormalities. 
A-D) Embryos at day E18.5 of the following genotypes: wild-type (A), ΔNp63+/- (B), 
ΔNp63-/- (C), and p63-/- (D). Arrows in panel (B) indicate extra folds of skin and in 
panel (C) indicate non-adherent skin. E-H) Hematoxylin and eosin stained cross sections 
of the skin of E18.5 embryos of the following genotypes: wild-type (E), ΔNp63+/- (F), 
ΔNp63-/- (G), and p63-/- (H). Arrows indicate basaloid cells above the basal layer of the 
epidermis. I-L) Immunohistochemistry for ΔNp63 in cross sections of E18.5 skin from 
embryos of the following genotypes: wild-type (I), ΔNp63+/- (J), ΔNp63-/- (K), and 
p63-/- (L). 
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4.4. A defect in skin differentiation in the ΔNp63-/- mice  
Studies from others and the Flores laboratory have shown that TAp63 and ΔNp63 have 
different roles in skin differentiation (Koster et al., 2005; Keyes et a., 2004; Truong et 
al., 2006; Su et al., 2009). In particular, Su et al. (2009) generated TAp63-/- mice that 
showed no defects in skin differentiation during embryonic development. Hence, I 
hypothesize that ΔNp63 is essential for proper epidermal differentiation. To test this 
hypothesis, differentiation marker analyses were performed with keratin 5 (K5) and 
keratin 14 (K14) as a basal layer marker, keratin 10 (K10) as a spinous layer marker and 
filaggrin (Fila) as a granular layer marker on E18.5 embryo skin. Surprisingly, all 
differentiation markers were expressed in ΔNp63-/- but the expression was not as robust 
as in wild-type embryos (compare Figures 20G & K to Figures 20F & J) suggesting an 
inhibition of differentiation in the absence of ΔNp63 (Figure 20C, G, and K). All 
differentiation marker expression was also expanded in ΔNp63+/- embryos (Figure 20B). 
Given the apparent disorganization of epidermis in ΔNp63 deficient embryos, I 
investigated whether expanded expression of differentiation markers in the ΔNp63 
embryos is due to improper epidermal differentiation. Double staining was performed 
using antibodies, K14 and K10. These overlap expression (Figure 20N & O) of two 
different layer markers, K14 and K10 in ΔNp63+/- and ΔNp63-/- embryos (Figure 20N & 
O).  
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Figure 20. ΔNp63 mutant mice display defects in epidermal differentiation.  
Immunofluorescence using skin from E18.5 day embryos of the indicated genotypes. 
Antibodies used are as follows: (A-D) keratin 5, (E-H) keratin 10, (I-L) filaggrin, and 
(M-P) keratin 14 (green) and keratin 10 (red). DAPI was used as a counterstain. 
Magnification 400X. 
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4.5. Aberrant proliferation in spinous layer of epidermis in ΔNp63-/- mice 
Improper differentiation and expansion of basal layer cells led me to ask whether 
this differentiation defect resulted from altered proliferation in the ΔNp63 ablated 
epidermis. To address this question, first, a BrdU incorporation assay was performed on 
embryonic day E18.5 embryos. The pregnant females were timed at 18.5days through 
ΔNp63+/- females intercrossing with ΔNp63+/- males and embryos were collected from 
the pregnant females at 18.5dpc. BrdU was injected 3 times in 1 hour interval into 
pregnant females and 1hour after the last injection embryos were harvested (Su. et al., 
2009). To count the number of proliferative cells in basal layer of epidermis, double 
staining was performed using antibodies against to K5 and BrdU (Figure 21A- C). Since 
there were BrdU positive cells above the basal layer, to determine the origin of the 
signal, double staining with K10 and BrdU was also performed (Figure 21D- F). Double 
positivity for K10 and BrdU was not clearly visualized in wild type skin, while there 
were double K10 and BrdU positive signals sectioned skins from ΔNp63+/- and ΔNp63-/- 
embryos. These results indicate that loss of ΔNp63 results in aberrant proliferation 
compared to wild type skin (Figure 21G & H). Since loss of ΔNp63 led to aberrant 
proliferation in epidermal layers, it prompted me to hypothesize that ΔNp63-/- 
keratinocytes proliferate in vitro.	   
 Epidermal keratinocytes were harvested from ΔNp63-/- epidermis and cultured. 
To measure the proliferation rate of epidermal cells from wild type and ΔNp63-/-, 
epidermal cells were cultured for 5 days and 10 days on J2-3T3 feeders (Appendix 3). 
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Interestingly, more cell numbers at indicated days in ΔNp63-/- epidermal cells 
(ΔNp63Δ/Δ keratinocytes have a similar result, data not shown) showed hyperproliferation 
and longer culture showed stem-like cell morphology in vitro (Figure 24A & B).  
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Figure 21. ΔNp63 mutant mice have a hyperproliferative epidermis. 
A-F) Double immunofluorescence using skin from E18.5 day embryos of the indicated 
genotypes. Antibodies used are as follows: (A-C) keratin 5 (K5, red) and BrdU (green) 
and (D-F) keratin 10 (K10, red) and BrdU (green). DAPI was used as a counterstain. 
Magnification 400X. G) Percentage of BrdU positive cells expressing K5. H) Percentage 
of BrdU positive cells expressing K10. Asterisks indicate statistical significance, 
(p<0.001). 
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4.6. Molecular mechanism contributing to the regulation of epithelial 
differentiation of ΔNp63 
 
4.6.1. ΔNp63 mutant mice phenocopy of DGCR8fl/fl;K14Cre+ and Dicerfl/fl;K14Cre+ 
mice hair follicle outgrowing. 
Phenotypic defects in stratification and proliferation observed in skin from the 
DGCR8fl/fl;K14Cre+ and Dicerfl/fl;K14Cre+ mice (Yi et al., 2006; Yi et al., 2009) were 
similar to phenotypes observed in the absence of ΔNp63, which include expansion of  
the basal layer, hyperproliferation, hair follicles evagination and a defect in 
differentiation. To determine whether there is outgrowing hair germ in ΔNp63+/- and 
ΔNp63-/- epidermis, like DGCR8fl/fl;K14Cre+ and Dicerfl/fl;K14Cre+mice, double 
staining on ΔNp63fl/fl;K14Cre+ and ΔNp63fl/+;K14Cre+ were performed for Lef1 as a 
hair germ marker (Figure 22) (Merrill et al., 2001). The ΔNp63+/- and ΔNp63-/- embryo 
epidermis at E18.5 showed hair germ outgrowth by confirmation of Lef1 expression 
(Figure 22B, C, F & G). Hence, I hypothesize that ΔNp63 regulates DGCR8 and/or 
Dicer in mice skin. 
 
4.6.2. DGCR8 is a unique target gene of ΔNp63. 
DGCR8 forms a complex with Drosha, which processes primary microRNAs to 
precursor microRNAs in the nucleus. Studies from the Flores laboratory (Su & 
Chakravarti et al., 2010) have reported that TAp63 transcriptionally regulates Dicer. 
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With phenotypic similarities between DGCR8fl/fl;K14Cre+ and Dicerfl/fl;K14Cre+mice 
with respect to epidermal development, I wanted to determine whether ΔNp63 regulates 
expression of the 3 microRNA-processing component genes. To address this question, q-
RT PCR was performed with primers for Dicer, DGCR8 and Drosha using RNA from 
E18.5 wild type and ΔNp63-/- mice skin. Interestingly, ΔNp63 only down modulates 
DGCR8 mRNA expression. However, none of Dicer and Drosha mRNA levels seemed 
to differ between two genotypes (Figure 22G). It prompted me to ask whether TAp63 
also regulates DGCR8 mRNA as similar in Dicer regulation (Su & Chakravarti et al., 
2010). To address this question, q-RT PCR was also performed for DGCR8 using RNA 
extracted from TAp63-/- keratinocytes. However, in the absence of TAp63, a DGCR8 
mRNA expression levels are not down modulated (Figure 22H), which indicates that 
ΔNp63 is a unique regulator of DGCR8 mRNA expression. 
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Figure 22. ΔNp63 deficient mice epidermis is reminiscent to DGCR8fl/fl;K14Cre+ 
and Dicerfl/fl;K14Cre+ mice.   
Immunfluorescence using skin from E18.5 day embryos of the indicated genotypes. A-
C) Lef1 (green) and DAPI (blue) or D-F) Lef1 (green) only. G) qRT-PCR for Dicer, 
DGCR8 and Drosha using total RNA from wild-type (WT) and ΔNp63-/- (ΔN-/-) 
epidermal cells. H) qRTPCR for DGCR8 using total RNA from wild-type (WT), ΔNp63-
/- (ΔN-/-) and TAp63-/- epidermal cells. 
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4.6.3. ΔNp63 transcriptionally regulates DGCR8 via direct binding to its promoter 
To further understand how ΔNp63 regulates DGCR8 gene expression and to 
address whether the DGCR8 gene down-regulation results from absence of p63 to 
transactivate the gene, chromatin immunoprecipitation (ChIP) analysis was performed 
using specific antibody for p63. 2 putative sites (site 1 and site 2) in the Intron1 of 
DGCR8 were found to be a binding consensus region where p63 could bind, however 
p63 only bound to site1 of DGCR8 promoter (Figure 23A). To verify whether that site is 
a specific binding site of p63, a set of non-specific primers were designed and located at 
500bp upstream from the site 1, indicating site 1 is specific for binding (Figure 23B). To 
further verify its binding on the promoter of DGCR8 can functionally regulate gene 
transcription, the DGCR8-Luciferase reporter gene construct (dgcr8 S) was constructed 
which included site1 sequence. Dgcr8 S was mutated (dgcr8 Sm) using a site-directed 
mutagenesis kit to change the consensus site from (ctgCATGtatctcctaagaagcCTTGcca) 
to (ctgTTTTtatctcctaagaagcTTTTcca), using a binding site that contains putative p63 
binding site from ChIP as a negative control.  Dgcr8 S or dgcr8 Sm were transfected 
with a p63 isoform expressing plasmid, TAp63 α, β or γ or ΔNp63 α, β or γ (Figure 
23D) into p53-/-;p63-/- MEFs. Only ΔNp63 isoforms could transactivate luciferase 
reporter gene activity but the mutated reporter construct was not transactivated by any of 
p63 isoforms (Figure 23D). This indicates that the binding site is specific for ΔNp63, 
but not for TAp63. This result is consistent with q-RT PCR for DGCR8 mRNA 
expression (Figure 22).  
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Figure 23. DGCR8 is transactivated by ΔNp63α, ΔNp63β andΔNp63γ .   
A & B) qRT-PCR of ChIP assay using wild-type (WT) and ΔNp63-/- (ΔN-/-) epidermal 
cells and indicating p63-binding site (site 1) or no binding of p63 to site 2 or non-
specific binding site (NSBS) (A) or no binding of p53 to the indicated sites (B). C) 
Schematic showing DGCR8-site 1 (dgcr8 S-) and DGCR8- mutant of site 1 (dgcr8 Sm-) 
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luciferase reporter genes. D) Luciferase assay for DGCR8 in p53-/-;p63-/- MEFs 
transfected with the indicated p63 isoforms and the indicated luciferase reporter gene. 
Each bar represents the average of the fold activation of three independent experiments. 
The asterisks indicate statistical significance (p-value <0.001). 
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4.6.4. Loss of ΔNp63 results in higher expression of the pluripotency regulators, 
Oct4, Sox2 and Nanog. 
We have seen the failure of terminal differentiation in ΔNp63 lacking skin. To 
characterize thoroughly the role of ΔNp63, I isolated cells and deleted the allele acutely 
to understand down stream consequence. Loss of ΔNp63 shows a hyperproliferation 
phenotype in embryos at E18.5 and also in vitro epidermal cell culture (Appendix 3). 
Interestingly, I observed that ΔNp63-/- epidermal cells exhibit a unique undifferentiated 
morphology that does not resemble keratinocytes. Moreover, when I ablated ΔNp63 by 
administering adenovirus-cre recombinase to ΔNp63fl/fl keratinocytes, a similar 
undifferentiated phenotype was observed within hours of ΔNp63 deletion (compare 
Figure 24A & B). Consistent with our model, DGCR8-/- embryonic stem (ES) cells have 
a hyperproliferation phenotype and a delayed differentiation defect (Melton et al., 2010; 
Suh et al., 2010). Also, in DGCR8-/- embryonic stem cells (ES), expression of Oct4, Sox2 
and Nanog genes were not diminished by differentiation stimulators, it resulted in 
delayed differentiation and hyperproliferation (Melton et al., 2010). To further elucidate 
the roles of ΔNp63 in differentiation, an in vitro system using primary epidermal cells 
was employed and cells were subjected to high calcium (1.6mM, Ca2+) to induce 
terminal differentiation (Su et al., 2009; Flores et al., 2000). To determine the efficiency 
of differentiation in vitro cell system, western analysis was performed to test protein 
expression levels with the use of differentiation markers (Figure 24C). Interestingly, 
filaggrin, a terminal differentiation marker, expression was too low to detect under high 
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calcium conditions. It indicates the possibility of delayed or improper differentiation 
both in vivo and in vitro due to loss of ΔNp63. 
I tried to address the question whether pluripotency regulating genes expression 
is modulated in ΔNp63-/- epidermal cells.  I observed that in ΔNp63 KO and cKO 
epidermal cells display high expression of Oct4, Sox2 and Nanog (Figure 24D-F). This 
corresponds to the pluripotent genes, Oct4, Sox2 and Nanog, in which the expression is 
concomitantly elevated in ΔNp63 deficient cells. Hence, I hypothesized that ΔNp63 
represses pluripotency regulators expression through the transcriptional regulation of 
DGCR8. To understand the molecular mechanism between DGCR8 and pluripotency 
regulators, its genes expression level was tested. The expression of pluripotent genes 
was down regulated to wild type level after DGCR8 restoration in the ΔNp63-/- 
epidermal cells (Figure 24B-D). An alternative approach to test the hypothesis was to 
perform a loss of function experiment with infecting of short-hairpin DGCR8 
(shDGCR8) virus into wild type epidermal cells and then expression levels of the 
pluripotency genes was determined. The expression pattern was found to be increased in 
shDGCR8 infected wild type epidermal cells (Appendix 4).  
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Figure 24. Oct4, Sox2 and Nanog are upregualted in ΔNp63 deficient epidermal 
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cells.  
A & B) Epidermal cells derived from the skin of ΔNp63 conditional knock out mice 
(fl/fl) (A) and ΔNp63fl/fl epidermal cells infected with adenovirus-cre for 6 hours to 
generate ΔNp63 deficient (Δ/Δ) epidermal cells. C) Western blot analysis of epidermal 
cells derived from mice of the indicated genotypes grown under conditions that promote 
keratinocyte differentiation (High Ca2+) and using the indicated antibodies. Actin was 
used as a loading control. D-F) qRTPCR using total RNA from mouse embryonic stem 
cells (ES) and epidermal cells of the indicated genotypes for Oct4 (D), Sox2 (E), and 
Nanog (F). Asterisks indicate statistical significance (p-value <0.001). G-L) 
Immunohistochemistry for Oct4 (G&H), Sox2 (I&J), and Nanog (K&L) in cross sections 
of E18.5 skin from embryos of the following genotypes: wild-type (G, I&K), and 
ΔNp63-/- (H, J&K). 
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4.6.5. Repression of mir470 and mir145 in ΔNp63-/- and Δ/Δ  epidermal cells 
correspond to elevated mRNA levels of Oct4, Sox2 and Nanog. 
ΔNp63 deficient epidermal cells had diminished expression of DGCR8, well-
known microRNA processor complex protein. This prompted us to search for 
microRNAs that might involve in this stem-like morphological phenotype in ΔNp63Δ/Δ  
epidermal cells. Earlier, Tay et al., and Xu et al. reported miR470 and miR145 are 
important regulators to commit embryonic stem cell undergoing differentiation (Tay et 
al., 2008; Xu et al., 2009). These microRNAs repress Oct4, Sox2 and Nanog, when ES 
cells commit to differentiation (Tay et al., 2008). Hence, the new hypothesis was 
whether ΔNp63 induces differentiation via DGCR8 regulation through miR470 and 
miR145. To test this hypothesis, Taqman based real time PCR was performed for 
miR470 and miR145. As expected, miR470 and miR145 were repressed by loss of 
ΔNp63. Indeed, this level was similar to ES cells in ΔNp63-/- epidermal cells and slightly 
higher in ΔNp63 acute deleted epidermal cells, ΔNp63Δ/Δ  (Figure 25B-D). To further 
understand the molecular mechanism, DGCR8 was restored using Flag-DGCR8 
retrovirus infection. MiR470 and miR145 expressions were found to be similar to the 
wild type epidermal cells (Figure 25E & F). These data indicate that ΔNp63 deficient 
epidermal cells might obtain pluripotency as a result of misregulation of repression of 
microRNAs, miR470 and miR145, on Oct4, Sox2 and Nanog via diminution of DGCR8.  
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Figure 25 Restoration of DGCR8 rescues defect in differentiation in ΔNp63 
deficient epidermal cells  
A) Western blot analysis of epidermal cells of the indicated genotypes with the 
antibodies shown. B-D) qRT-PCR using total RNA from epidermal cells of the indicated 
genotypes. Cells expressing DGCR8 are indicated by (pDGCR8). Expression of Oct4 
(B), Sox2 (C), and Nanog (D) were analyzed. E & F) TaqMan reverse transcriptase 
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mediated PCR for miR-470 (E) and miR-145 (F) using RNA from the indicated samples. 
Asterisks indicate statistical significance (p-value <0.001)   
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4.6.6. ΔNp63 regulates cell fate and cell differentiation via the regulation of 
DGCR8.  
ΔNp63 mutant cells resulted in transcriptional down regulation of DGCR8 that 
gave rise to pluripotency characteristics. I hypothesized that ΔNp63 governs proper 
terminal differentiation by transcriptional regulation of DGCR8 in the mouse epidermis. 
Previous studies have demonstrated that overexpression of Oct4 in wild type mouse 
keratinocytes changed their cell fate from keratinocytes to neuronal cells, when it 
cultured in neuroectodermal media (Grinnell et al., 2007). To test whether loss of ΔNp63 
led cells to differentiate to multiple cell fates, ΔNp63Δ/Δ  epidermal cells were cultured 
in neuroectodermal media. To determine whether DGCR8 is necessary for 
differentiation, I cultured cells absent or present DGCR8 in neuroectodermal media. As 
previously shown by Grinnell, epidermal cells changed cellular morphology to neuronal 
cells which were confirmed by the expression of neuronal cell markers, Nestin for 
neuronal membrane marker and NeuN for neurons by q-RT PCR primers designed 
against mRNA, with or without DGCR8 restoration in ΔNp63Δ/Δ epidermal cells 
(Figure 26A-C). It seems ΔNp63Δ/Δ epidermal cells no longer have keratinocyte cell 
fate, so they will be called epidermal cells. I transfected DGCR8 plasmid into acute 
deleted Δ/Δ  epidermal cells and subjected cells the high calcium (Ca2+, 1.6mM) to 
induce epidermal cells differentiation for a period of 3days. Differentiation marker 
western blot analyses were performed to determine whether terminal differentiation is 
rescued by restoration of DGCR8 (Figure 26D & E). I inferred from the western blot 
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analysis that restoration of DGCR8 rescued the differentiation defect in epidermal cells. 
The restoration of DGCR8 in ΔNp63 deficient cells rescued improper epidermal cell 
differentiation. Importantly, restoration of DGCR8 in ΔNp63 deficient cells resulted in 
the different cell fate to neuronal cells. Hence, transcriptional regulation of DGCR8 by 
ΔNp63 enabled processing the mature miR470 and miR145 to repress pluripotency 
genes, Oct4, Sox2 and Nanog, thereby differentiation defects were rescued in the ΔNp63-
/- mice skin (Figure 26D & E). 
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Figure 26. ΔNp63 deficient epidermal cells are pluripotent and can self-renew.  
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A-C) TaqMan reverse transcriptase mediated PCR for miR-295 (A), miR-302a (B) and 
miR-130b (C) using RNA from the indicated samples. Asterisks indicate statistical 
significance (p-value <0.001), D-F) ΔNp63 deficient epidermal cells (Δ/Δ) cultured 
under the following conditions: (D) keratinocyte media Low Ca2+, (E) keratinocyte 
differentiation media (High Ca2+), and (F) neuroectodermal media. G) Western blot 
analysis of epidermal cells of the indicated genotypes with (+pDGCR8) or without (-
pDGCR8) DGCR8 and using the antibodies shown. Actin was used as a loading control. 
H) qRT-PCR for nestin and NeuN using total RNA from the epidermal cells of the 
indicated genotypes. I-K) qRT-PCR using total RNA from epidermal cells of the 
indicated genotypes with (+retinoic acid: RA) or without (-retinoic acid: RA) RA. Cells 
expressing DGCR8 are indicated by (pDGCR8). Expression of MyoD; a mesoderm 
marker (I), AFP, an endoderm marker (J), and Nestin, an ectoderm marker (K) were 
analyzed. 
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4.7. Loss of ΔNp63 results in obtaining self-renewal capacity in epidermal cells 
To characterize whether ΔNp63 ablated epidermal cells obtain stem cell properties, such 
as self -renewal capacity, a clone formation assay was performed as previously described 
(Barrandon and Green, 1987; Flores et al., 2000). 4 X 105 acutely ablated ΔNp63 (Δ/Δ) 
epidermal cells were cultured on J2-3T3 feeders for 7 days interval until passage5 
(Figure 26F). To determine self-renewing capacity, cell numbers were counted and a 
BrdU incorporation assay was performed. Δ/Δ  epidermal cells maintained their 
proliferative capacity that was confirmed by cell numbers and percentage of BrdU 
positivity (Figure 26G & H) indicating the ability to self-renew.  
To determine whether the expression of pluripotency markers was sustained after 
serial passage in ΔNp63 deficient epidermal cells, I examined mRNA levels of Oct4, 
Sox2, and Nanog in wild-type (ΔNp63fl/fl) and ΔNp63Δ/Δ epidermal cells from passage 
1 to 5 (Figure 26I-K). 
Taken together, current model is built according to my study in terms of 
differentiation from these results indeed suggests that ΔNp63 induces terminal 
differentiation through regulation of DGCR8 as a key factor during embryo development 
(Figure 27). 
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Figure 27. ΔNp63 initiates epidermal differentiation through DGCR8. 
A) Epidermal colonies from wild-type and ΔNp63 deficient epidermal cells (Δ/Δ) 
cultured on J2 3T3 feeder layers and stained with rhodamine B. Passages 1 (P1), 3 (P3), 
and 5 (P5) are shown. B) Immunostaining for BrdU (green) and K5 (red) in passage 3 
and 5 wild-type (ΔNp63fl/fl) and ΔNp63Δ/Δ (Δ/Δ) epidermal cells. DAPI (blue) was 
used as a counterstain. White bar indicates 100 µm. C) Quantification of BrdU 
incorporation in colonies after 8 days in culture. Passages 1, 3, and 5 are shown. 
Experiments performed in triplicate. Asterisks indicate statistical significance (p-value 
<0.001). D-F) qRT-PCR from total RNA derived from wild-type (ΔNp63fl/fl) and 
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ΔNp63Δ/Δ (Δ/Δ) epidermal cells at passages 1, 3, and 5. Expression of Oct4 (D), Sox2 
(E), and Nanog (F) were analyzed. Experiments performed in triplicate. Asterisks 
indicate statistical significance (p-value <0.001). 
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CHAPTER 5.  
Roles of ΔNp63 in limb development, wound healing, and asymmetric cell division 
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5.1. Limb development and epidermal differentiation 
 
Rationale: Recently, I have demonstrated that ΔN63 transcriptionally regulates 
brachyury gene expression and that low levels of brachyury result in truncated limbs of 
p63 null mice (Cho et al., 2010). As expected, ΔNp63-/- mice also develop truncated 
limbs indicating that ΔNp63 is a regulator for limb formation (Cho et al. 2010; Cho et 
al., under review 2011). Brachyury was expressed at early embryonic day E5.5-E12.5 
and was regulated by ΔNp63 (Cho et al.). p63 was already expressed at embryonic day 
E8.5 before stratification occurred (Cho et al.; Koster et al., 2004; Laurikkala et al., 
2006).  
Stratification occurs with formation of limb bud at embryonic day E9.5 and is 
coincident with expression of K5 and K14 (Sun et al.). I tested whether ΔNp63 ablation 
between before- and after-differentiation differs from proper limb development. Hence, 
to delete ΔNp63 after commitment to differentiation, ΔNp63fl/fl mice mated with K14Cre 
transgenic mice (Jonkers et al., 2001) to obtain ΔNp63fl/fl;K14Cre.  
 
Hypothesis: I hypothesized that ΔNp63 regulates proper limb development before the 
limb bud starts differentiation. 
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5.1.1. Cre recombines 90% of ΔNp63 alleles in ΔNp63fl/fl;K14Cre+  (Δ/Δ) mice.  
To determine whether ΔNp63 functions before differentiation begins, K14Cre 
transgenic mice were used to delete ΔNp63 allele after differentiation began. K14Cre 
mice are transgenic mice. Cre is a recombinase that was controlled under the K14 
promoter (Jonkers et al., 2001). To segregate the difference between a germ line deletion 
and deletion after differentiation using K14Cre transgenic mice, ΔNp63fl/fl;K14Cre+ 
(Δ/Δ) mice were generated by crossing ΔNp63fl/fl mice and K14Cre transgenic mice 
(Jonkers et al., 2001). Since K14Cre transgenic mice were crossed to remove ΔNp63 
allele conditionally in K14 positive cells, to determine how much deletion of ΔNp63 
took place in the basal layer of epidermis, IHC staining was performed using ΔNp63 
specific antibody showed greater than 90% of ΔNp63 was deleted (Figure 28D).   
Epidermal differentiation remarkably occurred in ΔNp63fl/fl;K14Cre+ (Δ/Δ) 
mice. The multi-layered epidermis existed (Figure 29B & D) in ΔNp63fl/fl;K14Cre+ 
(Δ/Δ) mice. 
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Figure 28. Stratification occurred in ΔNp63fl/fl;K14Cre+ (Δ/Δ) mice epidermis. 
A & B) Hematoxylin and eosin stained cross sections of the skin of E18.5 embryos of 
the following genotypes: WT; K14Cre and ΔNp63fl/fl;K14Cre (Δ/Δ). C & D) 
Immunohistochemistry antibody against ΔNp63 stained cross sections of the skin of 
E18.5 embryos of the following genotypes: WT; K14Cre and ΔNp63fl/fl;K14Cre (Δ/Δ). 
(Cho & Flores, unpublished) 
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5.1.2.  ΔNp63 acts early in limb development and epidermal skin differentiation. 
A very interesting observation from ΔNp63fl/fl;K14Cre+ (Δ/Δ) mice, fore- and 
hind limbs formed in ΔNp63fl/fl;K14Cre+ (Δ/Δ) mice. Brachyury was regulated by 
ΔNp63 isoforms to form limbs, which I already demonstrated in in vitro cell system 
(Cho et al., 2010) and as previously shown in Chapter 4 in this thesis: ΔNp63 isoforms 
regulated brachyury during limb development and ΔNp63-/- mice developed truncated 
limbs and died within hours after birth with fragile and disorganized epidermis 
appearance (Cho et al., 2011 submitted). Koster (2007) and Cho (2010) have reported 
that ΔNp63 is expressed from embryonic day at E8.5~ E9.5. To further understand how 
ΔNp63 plays a role in limb developmental defects as seen in the p63-/- and ΔNp63-/- mice 
(Mills et al., 1999; Yang et al., 1999; Cho et al., submitted 2011), ΔNp63fl/fl mice were 
crossed with the K14Cre transgenic mice (Jonkers et al., 2001) to obtain double 
heterozygous mice (ΔNp63fl/+; K14Cre+). Subsequent mating by intercrossing a female 
ΔNp63fl/+; K14Cre+and a male ΔNp63fl/+; K14Cre+ mice gave rise to ΔNp63fl/fl; 
K14Cre+ (Δ/Δ) mice. Progenies were born with a Mendelian ratio and ΔNp63fl/fl; 
K14Cre+mice were viable at birth; however, they also died within hours after birth as 
observed in p63-/- and ΔNp63-/- mice. Importantly, the phenotype of ΔNp63fl/fl; K14Cre+ 
mice was dramatically different than  p63-/- and even ΔNp63-/- (Figure 29). ΔNp63fl/fl; 
K14Cre+ (Δ/Δ) mice developed proper face, ear and nose structures; in particular, limbs 
were remarkably well formed with little shortening in size and limbs from Δ/Δ mice 
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even had separate digit formation (Figure 29E, F, G& H). The digits are not completely 
separated but folded. They look similar to human’s foot and hand disfiguring 
appearances (AEC and EEC) (Figure 4).  
Additionally, in the dorsal view of ΔNp63fl/fl;K14Cre+ (Δ/Δ) mice limbs display 
thinner blood vessels. This result also indicates that ΔNp63 functions early in 
development, especially the differentiation of limb, epidermis and blood vessel 
formation. However, further investigations of blood vessel formation and complete limb 
formation have remained to be done.  
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Figure 29. The view of ΔNp63fl/fl;K14Cre+ (Δ/Δ) mice embryonic day at E18.5 
A & B) Macroscopic view of wild type and ΔNp63fl/fl;K14Cre+ (Δ/Δ) embryos at day 
E18.5. (White arrow indicates lip area in ΔNp63fl/fl;K14Cre+ and white circle indicated 
proper developed ear in ΔNp63fl/fl;K14Cre+. C & D) Mouth developed properly in 
ΔNp63fl/fl;K14Cre+ that does not show cleft lip but still eye lids are covered 
incompletely and E, F, G & H) limb and digit dorsal and ventral views from wild type 
and ΔNp63fl/fl;K14Cre+ (white arrow head indicates folded digits) (Cho and Flores, 
unpublished).  
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5.2. The role of ΔNp63 in Wound healing 
 
Rationale: Since ΔNp63-/- and ΔNp63fl/fl;K14Cre+(Δ/Δ) mice prematurely die, it 
becomes too difficult to study functions of ΔNp63 at adulthood, I decided to use an 
inducible knock out strategy to generate ΔNp63-/- mice at the adult stage using 
ΔNp63fl/fl;K14CreER  (Vasioukhin et al., 1999) conditional knock out mice (ΔNp63 
becomes null upon induction of Cre recombinase). Cre-recombinase is activated by an 
estrogen receptor induction in K14 positive cells. This transgenic mouse is very useful 
upon consideration of early death of ΔNp63-/- and ΔNp63fl/fl;K14Cre+(Δ/Δ) mice. 
 
Hypothesis:  ΔNp63 plays a critical role in the maintenance of proper epithelialization 
through life. 
 
5.2.1. Loss of ΔNp63 accelerates healing process by hyperproliferation after wound. 
Accelerated proliferation and improper differentiation seemed to be the main 
characteristics exhibited by loss of ΔNp63. To further decipher this phenomenon, a 
wound-healing assay was performed to 5-week-old mice from wild type, p63+/-, 
ΔNp63+/-, ΔNp63fl/+;K14CreER+ and ΔNp63fl/fl;K14CreER+. The wound healing assay 
tests the capacity of the epidermal cells to differentiate and proliferate in vivo during 
adulthood (Su et al., 2009b). To generate a wound, I used the punch biopsy approach in 
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wild type and ΔNp63+/- at 5 week-old-age mice since ΔNp63-/- mice do not survive until 
adulthood, and we have seen a hyperproliferation phenotype in epidermal layers, basal 
and spinous layer of epidermis, from ΔNp63+/- mice (Figure 20). A wound healed more 
rapidly in ΔNp63+/- mice than wild type mice (Figure 30A).  This was consistent with 
previous proliferation assay using skin sections from embryos (Figure 20).  
I also used ΔNp63fl/fl;K14CreER+ mice to recombine ΔNp63 allele to delete only 
in K14 positive basal layer of cells by tamoxifen administration at 5week-old-age; 
ΔNp63 was ablated to about 50%, as confirmed by PCR analyses (Figure 30C). 
Tamoxifen was administrated by painting method once a day for 3days (100ul of 
100mg/ml). After tamoxifen treatment for 3days, the skin was irritated and showed 
thickening and fragility in ΔNp63fl/fl;K14CreER+ mice. Then I wounded on back skin by 
punch biopsy and measured the percent of open wounds. ΔNp63fl/fl;K14CreER+ healed 
faster than control, WT;K14CreER+ and ΔNp63fl/+;K14CreER+ (Figure 30B). Since 
recombination rate is about 50% (Δ/Δ), it was thought to be ΔNp63+/-. Wound from 
ΔNp63Δ/Δ mice showed faster healing than wild type and ΔNp63Δ/+ (Figure 30B) 
suggesting that dosage of ΔNp63 is important to maintain cell proliferation and 
differentiation. However a rigorous study is still warranted to understand this matter 
further.  
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Figure 30. Wound healing is accelerated in ΔN63 deficient mice skin 
A) A graph of open wound (%) measured every day after wounding in 5week-old mice. 
The following genotypes are used for WT and ΔNp63+/- , B) A graph of open wound (%) 
measured everyday after wound in 5week-old mice. The following genotypes are used 
for WT, ΔNp63Δ/Δ and ΔNp63Δ/+, C) WT, ΔNp63Δ/Δ and ΔNp63Δ/+ mice wounding after 5 days, 
white arrows indicate closed one and D) PCR analysis to check recombination after 
tamoxifen treatment. (Cho & Flores, unpublished) 
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5.2.2. Hyperproliferation results in rapid healing after wound in ΔNp63+/- 
To determine whether faster healing occurs in later adulthood, I used 9month-old 
mice. Indeed, even 9-month-old ΔNp63+/- mice still healed faster than wild type mice. To 
figure out what promotes faster healing, I performed BrdU incorporation before I 
collected wounded skins to test proliferation. I observed hyperproliferation in ΔNp63+/- 
mice epidermis (Figure 31). Indeed, there were two epithelial tongues in ΔNp63+/- but 
one in wild type and p63+/- (Figure 31C, F & I). A healing process was faster in 
ΔNp63+/- mice than in both wild type and p63+/- mice. Proliferation was higher in 
ΔNp63+/- mice epidermis (Figure 31) with aberrant proliferation not only in basal layer 
but also in none basal layer, the spinous layer of embryonic epidermis (Figure 20).  
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Figure 31. A graph of open wound (%) measured everyday after wound in 9 month 
old mice A) and incorporation of BrdU at wound healing region, B) Hematoxylin and 
eosin stained cross sections of the skin of 9 month old mice after wound healing in the 
following genotypes: C, D) WT, F, G) ΔNp63+/- and I, J) p63+/- (6X magnification: C, F, 
I and 40X magnification: D, G, J) BrdU stained cross sections of the skin of 9 month old 
mice after wound healing in the following genotypes: E) WT, H) ΔNp63+/- and K) p63+/- 
(200X magnification: E, H, K) Black arrow heads indicate epithelial tongue and red 
arrow heads indicate BrdU positive cells. (Cho & Flores, unpublished) 
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5.2.3. Loss of ΔNp63 cells has a defect in orientation of cell division during 
development 
During the healing process after wounding, I demonstrated that non-basal layer 
cells retained proliferative capacity in ΔNp63+/- skin. Under wounded condition, 
epithelial cells divide fast to make up for the loss during wound repair. During early 
embryonic stages, cells divide symmetrically before differentiation and then asymmetric 
cell division occurs while undergoing differentiation (Lechler and Fuchs, 2005). 
Asymmetric cell division promotes stratification and differentiation in skin (Lechler and 
Fuchs, 2005). The Fuchs laboratory showed that LGN is a regulator of cell division 
orientation (Lechler and Fuchs, 2005). 
 Because of defects in the hyperproliferation and differentiation in our mouse 
model, I tested the orientation of cell division. I examined day E18.5 embryo skins from 
wild type, ΔNp63-/- and TAp63-/- (Figure 32 A- C) when the cells have already 
undergone differentiation. To determine orientation of mitotic cell division, wild type, 
ΔNp63-/- and TAp63-/- skin were used. Wild type and TAp63-/- skin cells followed a 
perpendicular division pattern about 70% of epidermal cells while ΔNp63-/- epidermal 
cells have been divided in parallel division orientation (Table 3).  
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Figure 32. Asymmetric cell division is impaired by loss of ΔNp63 embryo at day 
E18.5. Immunofluorescence using an antibody for Collagen type IV (ColIV), a marker 
of basement membrane and counterstained with TO-PRO3. Genotypes of analyzed 
embryos are: A) WT, B) ΔNp63-/- and C) TAp63-/-. White broken circle indicates a 
mitotic cell and white broken line for basement membrane.  (Cho & Flores, 
unpublished) 
 
 
 
Table 3. Cell division ratio (Cho & Flores, unpublished) 
 WT ΔNp63-/- TAp63-/- 
Parallel 26.3% 66.7% 22.2% 
Perpendicular 73.7% 33.3% 77.8% 
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5.2.4. ΔNp63 regulates LGN, a marker of cell orientation, by indirectly binding to 
its promoter. 
Hyperproliferation occurred in epidermal cells of DGCR8fl/fl;K14Cre mice (Yi et 
al. 2009) and loss of DGCR8 in embryonic stem cells (ESC) showed a hyperproliferation 
phenotype (Melton et al., 2010). In Chapter 4, I showed that ΔNp63 regulates DGCR8 
and a diminution of DGCR8 also has differentiation defect in ΔNp63 ablated epidermal 
cells. Asymmetric cell division controls stratification and differentiation that is regulated 
by LGN (Lechler and Fuchs, 2005).  
To further understand how ΔNp63 regulates cell division and promotes wound 
repair, I tested mRNA levels of LGN found that it is expressed locally in the nucleus 
during asymmetric cell division (Lechler and Fuchs, 2005). I observed downregulation 
of LGN in ΔNp63-/- skin but not in TAp63-/- skin indicating that ΔNp63 specifically 
regulates for LGN gene expression and cell division orientation (Figure 33A). This 
result is consistent with asymmetric cell division that occurs in wild type and TAp63-/- 
skin (Figure 33).  
To further understand whether LGN downregulation results from transcriptional 
regulation of ΔNp63, I performed chromatin immunoprecipitation (ChIP) analysis using 
p63 and p53 antibodies. I searched 2000bp upstream of the 5’UTR of the LGN gene and 
found 3 putative sites where p63/p53 might bind to the promoter of LGN. However, p63 
did not bind to LGN promoter whereas p53 did in ΔNp63-/- epidermal cells (Figure 33B 
& C). This clearly implicates binding activity of p53 to the promoter of LGN. This data 
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could imply that there is a correlation between ΔNp63 and p53 to regulate LGN. 
However, further analysis is still required.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33.  LGN is downregulated in ΔNp63-/- epidermal cells through DGCR8 
regulation.  A) The value is normalized to IgG from wild type, ΔNp63-/- and TAp63-/- 
embryos skin, Real time PCR analysis using 2 primer sets for LGN using ChIP-DNA 
using antibodies p63 B) and p53 C) from WT and p63-/- ;p19-/-keratinocytes.  D) After 
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DGCR8 restoration, cells are harvested and q-RT PCR for for LGN in RNA from wild 
type and ΔNp63Δ/Δ with or without DGCR8. The asterisks indicate statistical significance 
(p-value <0.001). (Cho & Flores, unpublished)  
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5.2.5. Restoration of DGCR8 rescues expression of LGN in ΔNp63-/- keratinocytes 
There is another question of whether any regulation exists between DGCR8 and 
LGN in ΔNp63-/-. LGN is implicated in asymmetric cell division that results in defects in 
stratification and differentiation (Lechler and Fuchs, 2005). DGCR8-/- embryonic stem 
cells (ESC) showed proliferation and differentiation defects (Melton et al., 2010). To 
address this question, DGCR8 was restored into ΔNp63-/- epidermal cells. The result is 
that the expression level of LGN mRNA was dramatically increased in ΔNp63-/- 
epidermal cells (Figure 33D). This data indicates that DGCR8 regulates controlling 
LGN to control asymmetric cell division in ΔNp63-/- epidermal cells. However, further 
analysis is still desired. 
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5.2.6. Loss of ΔNp63 shows a straight orientation of hair follicle growth.  
 Another interesting observation from ΔNp63+/- skin is that hair follicle 
orientation is perpendicular to the basement membrane of epidermis (Figure 34B). This 
hair follicle orientation is controlled by cell division and morphogenesis regulating 
signals during development (Ciruna et al., 2006; Gong et al., 2004). About 30% of 
epidermal skin demonstrated hair follicle orientation defect in ΔNp63+/- skin.  
 
 
Figure 34. The orientation of hair follicle growth is straight in ΔNp63 heterozygote 
embryos at E18.5. Hematoxylin stained cross sections of the skin of E18.5 embryos of 
the following genotypes: WT and ΔNp63+/-. (Cho & Flores, unpublished) 
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CHAPTER 6.  
CONCLUSION & DISCUSSIONS 
 
 
 
 
 
 
Some parts of this chapter were modified from the following journals. 
1. Cho MS, Chan IL and Flores ER. Cell Cycle 9:12, 1-8; June 15, 2010 ΔNp63 
transcriptionally regulates brachyury, a gene with diverse roles in limb development, 
tumorigenesis and metastasis. Reproduced with permission from Cho et al. and 
copyright clearance center. 
2. Su X, Cho MS, Gi Y, Ayanga BA, Sherr CJ, and Flores ER. EMBO J. 2009 Jul 
8;28(13):1904-15. Rescue of key features of the p63-null epithelial phenotype by 
inactivation of Ink4a and Arf. Reproduced with permission from Su et al. and 
copyright clearance center. 
3. Min Soon Cho, Xiaohua Su, Deepavali Chakravarti, Arianexys Aquino, Nicole 
Müller, Avinashnarayan Venkatanarayan, Io Long Chan, Young Jin Gi, & Elsa R. 
Flores. ΔNp63 induces terminal differentiation through transcriptional regulation of 
DGCR8 and suppression of pluripotency factors. 
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Chapter6. Conclusions and Discussions  
  
During my thesis work, I demonstrated that one of the essential functions 
necessary for the maintenance of the epithelium is tied to the repression of the Ink4a-Arf 
locus by p63, especially ΔNp63 isoforms and a complex network of genes regulated by 
p63 in multiple processes: stem cell proliferation, differentiation and adhesion for the 
maintenance of the integrity and development of the skin (Su et al., 2009).  
Second, I showed that the transcriptional network regulated by ΔNp63 during 
limb development and tumorigenesis acts through the transcriptional activation of 
brachyury (Cho et al., 2010). The biological significance of ΔNp63 overexpression is not 
completely understood in cancer. Previous studies have shown that ΔNp63 primarily 
serves to inactivate p53 and the full-length isoforms of p63 and p73, TAp63and TAp73, 
leading to a diminution in the ability of these p53 family members to induce apoptosis, 
cell cycle arrest, and other critical anti-tumorigenic processes that ultimately lead to 
tumor formation (Lanza et al., 2006; Yang et al., 1998).  
Third, I showed that ΔNp63 is a critical factor for the induction of epidermal 
differentiation and appropriate stratification (Cho et al., submitted 2011). In the absence 
of ΔNp63, a rudimentary and disorganized epidermis forms around the developing 
mouse embryo. ΔNp63+/- mice show an even more striking phenotype in terms of the 
disorganization of the developing epidermis with evaginating hair germs. These 
epidermal phenotypes are reminiscent of mice lacking DGCR8 and Dicer expression in 
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the skin (Yi et al., 2006; Yi et al., 2009). Accordingly, ΔNp63 deficiency resulted in low 
levels of DGCR8 and the miR-470 and miR-145, which were critical repressors of the 
pluripotency factors, Oct4, Sox2, and Nanog (Tay et al., 2008; Xu et al., 2009) (Figure 
27). I found that in the absence of ΔNp63 all three of these pluripotency factors were 
expressed at levels comparable to that found in mouse embryonic stem cells and that 
ΔNp63 deficient epidermal cells could self renew and differentiate into multiple cells 
fates after re-expression of DGCR8. Importantly, I found that ΔNp63 is a transcriptional 
activator of DGCR8. These data indicate that ΔNp63 is a critical regulator of terminal 
differentiation through the transcriptional activation of a critical factor in miRNA 
biogenesis. 
 
6.1 Rescue of key features of the p63-/- epithelial phenotype by inactivation of Ink4a 
and Arf. 
Two p63-null mouse models have been generated. Each shows similar 
phenotypes such as defects in stratified epithelium, truncated limbs, severe defects in 
craniofacial structures and ectodermal derived appendage malformation. However, there 
are at least two distinct interpretations of the data because of the complexity of the 
transcriptional network regulated by p63 (Mills et al., 1999; Vigano and Mantovani, 
2007; Yang et al., 1999). p63 regulates numerous transcriptional network of target genes 
in the maintenance of the integrity of stratified epithelium with essential functions in 
differentiation and cell adhesion (Vigano and Mantovani, 2007).   Recent evidence has 
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also indicated that p63 is essential for the proliferative potential of the epidermal stem 
cells (Senoo et al., 2007).  Prior to our study, the mechanisms governing epidermal 
differentiation and maintenance of stem cell proliferation were not known. 
 As a tumor suppressor gene Ink4a-Arf is well studied. Recent study showed that 
repression of the Ink4a-Arf locus by Bmi-1 (a polycomb complex protein) playa a 
pivotal role in the maintenance of stem cell properties both in hematopoietic stem cells 
and neural stem cells (Bracken et al., 2007; Bruggeman et al., 2005; Molofsky et al., 
2005; Molofsky et al., 2003). Bmi-1 represses the Ink4a-Arf locus. The epidermis is also 
an essential organ to continue homeostasis in order to maintain skin structure and is 
needed to retain stem cell proliferation and differentiation through life. However Bmi-1 
is not required for the development of the epithelium indicating that other repressors of 
the Ink4a-Arf locus exist in the epidermis to allow for stem cell renewal and proliferation 
(Senoo et al., 2007; van der Lugt et al., 1994). Indeed, inactivation of Arf or Ink4a 
rescues many of the defects seen in the p63-null mouse limb formation and epidermal 
cell proliferation. We demonstrated this by generating p63-/-;Arf-/- or p63-/-;Ink4a-/- mice.  
Both of these double mutant mice showed a remarkable rescue of the p63-/- phenotype 
exhibiting K5 and K10-expressing epidermal sheets around most of the embryos.  The 
rescue is more impressive in the p63-/-;Ink4a-/- mice with 85% of the skin of the 20 
embryos examined having K5 and K10 positive cells.  Remarkably, these mice exhibited 
evidence of hair follicles that stain positively for the hair follicle marker Lhx2 and K15 
(Liu et al., 2003b; Rhee et al., 2006) indicating some degree of restoration in the 
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epidermal stem cell compartment.  In contrast, K5 positive cells were only apparent in 
0.3% of the skin in the twenty p63-/- embryos consistent with previously published data.  
While the epithelium in the double mutants surrounded the embryo, the skin on these 
mice was still fragile and detached easily from the embryo as be shown in Fig. 8C & D. 
p63 has previously been shown to regulate genes involved in cell–cell adhesion. Loss of 
Ink4a or Arf rescues the proliferative and differentiation markers expression defects in 
keratinocytes deficient for p63.  These data suggest the presence of a complex network 
of p63 targets in the development of a stratified epithelium.  Here, we show a clear 
rescue of the proliferation defect of p63-/- keratinocytes; cells lacking Ink4a or Arf and 
p63 proliferate to wild type levels by BrdU incorporation assay.  
 p63 has been shown to have p53-dependent and -independent activities to 
promote cell survival and stem cell maintenance (Truong et al., 2006). Our analysis of 
p53-/-;p63-/- embryos are compatible with these findings. Apart from that, these genetic 
experiments strongly support the view that Ink4a and Arf have p53-independent 
activities in the rescue of keratinocytes stem cell proliferation in absence of p63. 
 Here, we demonstrated that one of the essential functions necessary for the 
maintenance of the epithelium is tied to the repression of the Ink4a-Arf locus by p63, and 
especially the ΔNp63 isoform (Su et al., 2009a). This argues for a complex network of 
genes regulated by p63 in multiple processes: stem cell proliferation, differentiation and 
adhesion for the maintenance of the integrity and development of the skin.  These data 
reveal a novel p53-independent mechanism for the restoration of the proliferative 
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potential of epidermal stem cells in the absence of p63. The molecular mechanisms 
regarding cell adhesion still remain to be addressed.  
 
6.2 ΔNp63 transcriptionally regulates brachyury, a gene with diverse roles in limb 
development, tumorigenesis and metastasis. 
I have identified brachyury, a gene that plays diverse roles in limb development 
and tumorigenesis, as a novel transcriptional target of p63, especially the ΔNp63 
isoform.  Importantly, brachyury is critical for appropriate formation of the apical 
ectodermal ridge (AER) that is essential for limb formation during embryogenesis (Liu 
et al., 2003).  Similarly, p63 is expressed on the AER and is also essential for limb 
formation (Mills et al., 1999; Yang et al., 1999; Lo Iacono et al., 2008). Here, I provide 
evidence that p63, specifically the ΔNp63α and -β but not –γ isoforms are critical for 
transcriptional regulation of brachyury during embryogenesis when the AER is formed.  
Interestingly, brachyury is highly expressed in many cancers, reminiscent of the 
pattern of expression of the ΔNp63 isoforms in many human tumors.  I have shown that 
ΔNp63 is also essential for expression of brachyury in tumors and that downregulation 
of ΔNp63 in cells from these tumors results in a diminution of brachyury expression and 
a decrease in cell proliferation. Our data provides a basis for further investigation of 
treatment of tumors with high levels of brachyury through inhibition of ΔNp63. 
The transcriptional network regulated by ΔNp63 during limb development and 
tumorigenesis is not well understood.  Based on the knowledge that p63 transcriptionally 
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regulates a large network of genes in multiple processes, p53-dependent or –independent 
way, it is likely that p63 also transcriptionally regulates multiple targets during limb 
development.  A recent study has shown that p63 transcriptionally regulates Dlx5 and 
Dlx6, transcription factors that play important roles in limb morphogenesis (Lo Iacono et 
al., 2008). This study found that the ΔNp63α isoform leads to the highest transactivation 
of Dlx5 and Dlx6.  Similarly, we found that the ΔNp63 isoforms had the highest activity 
at the brachyury promoter; however, ΔNp63α and ΔNp63β, and not ΔNp63γ, resulted in 
transactivation of a brachyury-luciferase reporter gene.  Together, these results suggest 
that the ΔNp63 isoforms likely transcriptionally regulate distinct sets of targets in limb 
development.  Our data are further supported by the in vivo phenotypes of the p63-/- mice 
(Mills et al., 1999; Yang et al., 1999), which have severely truncated limbs, and the 
TAp63-/- mice, which develop normal limbs (Su et al., 2009) and have no transcriptional 
activity at the brachyury promoter, indicating that only the ΔNp63 isoforms are critical 
for appropriate limb development. High levels of expression of ΔNp63 have been 
detected in many tumors.  ΔNp63 is highly expressed in tumors of epithelial origin like 
some head and neck squamous cell carcinomas and prostate, lung, and mammary 
adenocarcinomas (Flores, 2007; Flores et al., 2005).  The biological significance of 
ΔNp63 over expression is not completely understood in cancer.  Previous studies have 
shown that ΔNp63 primarily serves to inactivate p53 and the full-length isoforms of p63 
and p73, TAp63and TAp73, leading to a diminution in the ability of these p53 family 
members to induce apoptosis, cell cycle arrest, and other critical anti-tumorigenic 
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processes that ultimately lead to tumor formation (Lanza et al., 2006; Yang et al., 1998).  
Our data demonstrate that ΔNp63 also plays an active role in transactivating genes 
involved in the tumorigenic process through transcriptional activation of brachyury.  
Importantly, brachyury is highly expressed in chordoid cancer cells, chordoma, and 
chondrosarcoma, a malignant bone tumor originating in the cartilage (Yang et al., 2009; 
Vujovic et al., 2006).  Chordoid cells are those that resemble notochordal tissue. Because 
brachyury is essential for notochord formation and differentiation, misexpression or 
overexpression of brachyury can lead to the formation of tumors with chordoid features.  
Interestingly, ΔNp63 is highly expressed in invasive urothelial carcinomas with a 
chordoid morphology that resembles chondrosarcoma (Cox et al., 2009).  Consequently, 
brachyury and ΔNp63 are important biomarkers for these tumors and their expression is 
likely intimately linked. 
 Taken together, I have shown that ΔNp63 can transcriptionally regulate 
brachyury.  This regulation is critical during limb development and in the formation of 
tumors arising from the notochord.  Given the transcriptional regulation of brachyury by 
ΔNp63 and the diminution in cell proliferation in tumor cells after concomitant 
knockdown of ΔNp63 and brachyury, ΔNp63 is also a potential target for therapy of 
patients with tumors that have chordoid features.  Further investigation into therapeutic 
outcomes of patients with high levels of ΔNp63 and brachyury is essential to determine 
whether inhibitors of ΔNp63 will benefit cancer patients with alterations in this pathway. 
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6.3. ΔNp63 induces terminal differentiation through transcriptional regulation of 
DGCR8 and suppression of pluripotency factors. 
 Here, we show that ΔNp63 is a critical factor for the induction of epidermal 
differentiation and appropriate stratification. In the absence of ΔNp63, a rudimentary, 
disorganized epidermis forms around the developing mouse embryo. ΔNp63 
heterozygous mice show an even more striking phenotype in terms of the 
disorganization of the developing epidermis with evaginating hair germs. These 
epidermal phenotypes are reminiscent of mice lacking DGCR8 and Dicer expression in 
the skin (Yi et al., 2006; Yi et al., 2009). Accordingly, ΔNp63 deficiency resulted in low 
levels of DGCR8 and miRNAs, miR-470 and miR-145, which are critical repressors of 
the pluripotency factors, Oct4, Sox2, and Nanog (Tay et al., 2008; Xu et al., 2009) 
(Appendix 5). We found that in the absence of ΔNp63 all three of these pluripotency 
factors were expressed at levels comparable to that found in mouse embryonic stem cells 
and that ΔNp63 deficient epidermal cells can self renew and differentiate into multiple 
cells fates after re-expression of DGCR8. Importantly, we found that ΔNp63 is a 
transcriptional activator of DGCR8. These data indicate that ΔNp63 is a critical regulator 
of terminal differentiation through the transcriptional activation of a critical factor in 
miRNA biogenesis (Appendix 5). The presence of a rudimentary epidermis in ΔNp63-/- 
mouse embryos and the ability of ΔNp63 deficient epidermal cells to self-renew was 
quite surprising. The roles of p63 in epidermal morphogenesis have been the subject of 
heated controversy. Experimental evidence supports a role for p63 in both stem cell 
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proliferation and in the initiation of differentiation (Koster et al., 2004; Mills et al., 1999; 
Senoo et al., 2007; Yang et al., 1999). Elegant experiments using p63 deficient epithelial 
cells demonstrated that p63 is required for stem cell proliferation (Senoo et al., 2007). 
Also, data from an equal number of studies using p63-/- mice showed that p63 is 
required for proper differentiation of epithelial tissues (Koster et al., 2004). Most of 
these studies were performed using mouse models that are deficient for all isoforms of 
p63 making the interpretation of the data difficult to decipher due to the existence of 
multiple p63 isoforms. More recently, experiments have been performed using in vivo 
siRNA knock down of ΔNp63α, the isoform predominantly expressed in the skin. While 
this mouse model has provided valuable insight into transcriptional targets of ΔNp63α, it 
differs from our ΔNp63 knockout mice in two ways: 1.) the deletion of ΔNp63 was 
incomplete due to siRNA technology and 2.) ΔNp63 was deleted in K14-expressing 
cells, after the commitment to differentiation. 
Therefore, our unique mouse model has unveiled unknown functions of the ΔNp63 
isoforms in epidermal stem cell proliferation and in the induction of epidermal 
differentiation. Importantly, ΔNp63 indirectly regulates the expression of the 
pluripotency factors Oct4, Sox2, and Nanog by direct transactivation of DGCR8. 
Our data indicate that expression of DGCR8 is critical for terminal differentiation of 
ΔNp63 deficient cells into multiple cell fates. The phenotype of ΔNp63+/- and ΔNp63-/- 
embryos is similar to that of mice with DGCR8 ablated in K14 expressing cells within 
the epidermis. All three of these mouse models have a hyperproliferative epidermis and 
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hair germs that evaginate instead of invaginate (Yi et al., 2006; Yi et al., 2009). 
Moreover, DGCR8-/- embryonic stem cells continue to self-renew and fail to undergo 
terminal differentiation. 
Similarly, ΔNp63-/- epidermal cells continued to self-renew in clonogenic assays while 
wild-type epidermal cells senesced. ΔNp63-/- epidermal cells also continue to express 
markers of pluripotency, Oct4, Sox2, and Nanog, after multiple passages and only 
terminally differentiate after re-expression of DGCR8. Contrary to one of the current 
models that proposes that expression of ΔNp63 induces pluripotency, our data favor a 
model whereby complete deletion of ΔNp63 induces pluripotency in epidermal stem 
cells and likely in other progenitor cells where ΔNp63 is normally expressed. 
In summary, ΔNp63 is required for transcriptional activation of DGCR8 in the 
developing epidermis. DGCR8 is essential for epidermal morphogenesis; therefore, in 
the absence of ΔNp63, the epidermal stem cells in the developing skin fail to suppress 
expression of Oct4, Sox2, and Nanog and therefore fail to terminally differentiate. These 
findings have important implications for the function of ΔNp63 in cancer where its 
expression is often dysregulated (Flores, 2007). In the future, understanding the 
mechanisms employed by the individual p63 isoforms in maintaining progenitor and 
stem cells in various tissues is key to understanding its complex roles in cancer 
development and metastasis.  
 
6.4. ΔNp63 indirectly controls asymmetric cell divisions through LGN via 
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regulation of DGCR8.  
Based on other studies on asymmetric cell divisions, we knew that this event is 
required for deciding cell fate during embryogenesis (Artavanis-Tsakonas et al., 1999; 
Rohrschneider and Nance, 2009; Schuurmans and Guillemot, 2002; Segalen and 
Bellaiche, 2009). However, in adult mouse epidermis, perpendicular spindle orientation 
is observed in only ~3% of cells. This is too small a fraction to account for the 
asymmetric divisions in this tissue. Thus, alternative mechanisms might exist to achieve 
the asymmetric stem cell division in this system. Asymmetric cell divisions are also 
implicated in skin epidermal differentiation. That is critical for stratification and 
differentiation (Lechler and Fuchs, 2005). In this study, p63 was implicated as an 
important gene, as p63-/- epidermal cells showed a defect in asymmetric cell division. 
However, underlying molecular mechanisms are largely unknown. Here I reported my 
preliminary data showing LGN, which is one of spindle asymmetric orientation regulator 
genes, to be regulated by ΔNp63, not TAp63. It is consistent with TAp63-/- exhibiting no 
asymmetric cell division defect. By restoring DGCR8, its mRNA expression level was 
elevated to wild type level. However, chromatin immunoprecipitation (ChIP) assay 
showed that LGN was indirectly regulated by ΔNp63. Using p53 antibody for 
immunoprecipitation in p63-/- epidermal cells, I observed binding at the LGN promoter 
which indicates that ΔNp63 is required but not p53. p53 has not yet been implicated in 
asymmetric cell divisions. In summary, LGN might be regulated by indirectly ΔNp63 in 
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asymmetric cell division. There may be some other mediators involved in the regulation 
between ΔNp63 and LGN that could be p53 dependent.  
 
In summary, ΔNp63 is required for transcriptional activation of DGCR8 for 
proliferation and differentiation in developing epidermis. DGCR8 is essential for 
epidermal morphogenesis; therefore, in the absence of ΔNp63, the epidermal stem cells 
in the developing skin fail to suppress expression of Oct4, Sox2, and Nanog and 
therefore fail to terminally differentiate. Even in repression of the Ink4a-Arf locus in p63 
null background, epidermal terminal differentiation is still not complete since there is no 
DGCR8 involvement to differentiate by losing ΔNp63. These findings have important 
implications for the function of ΔNp63 in cancer where its expression is often 
dysregulated (Flores, 2007). In the future, understanding the mechanisms employed by 
the individual p63 isoforms in maintaining progenitor and stem cells in various tissues 
will be key to understanding its complex roles in cancer development and metastasis. 
The unique isoform specific conditional knock out mice model from Flores laboratory 
will provide a robust model with which to explore these questions.  
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APPENDIX 
 
 
 
 
Appendix 1. Mitotic Figures in Developing Epidermis from a wild type embryo at 
18.5 Days of epidermal keratinocytes in the basal layer of developing epidermis 
undergo apical-basal cell divisions (A), giving rise to cells in the intermediate layer, 
which divide laterally (B). (Cho & Flores Unpublished data) A broken white circle 
indicates a mitotic cell in the basal layer and broken line indicates a basement membrane 
between dermis and epidermis. 
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Appendix 2. ΔNp63 ablation shows lower microRNA expression. 
Total RNA is extracted from ΔNp63fl/fl and ΔNp63Δ/Δ keratinocytes. Northern analysis 
was used to detect precursor and mature forms of microRNA 200b expression (Cho & 
Flores Unpublished data). 
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Appendix 3. ΔNp63 ablation shows hyperproliferation in epidermal cells. 
*p < 0.03 A graph of cell numbers at indicated days (Day 0, 5 and 10). An asterisk 
showed statistically significant. 
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Appendix 4. DGCR8 knock down reminiscent gene expression. Oct4, Nanog and 
Sox2 are downregualted in wild type epidermal cells by just knocking down DGCR8 
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using shDGCR8. A) Western blot analysis for DGCR8. B, C & D) qRT-PCR for Oct4, 
Nanog and Sox2 in RNA from wild type and ΔNp63-/- epidermal cells and miR470 and 
miR145 are downregualted in wild type epidermal cells by just knocking down DGCR8 
using shDGCR8.E & F) qRT-PCR for miR470 and miR145 in RNA from wild type and 
ΔNp63-/- epidermal cells 
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Appendix 5. ΔNp63 initiates epidermal differentiation through DGCR8. 
In normal tissue differentiation, ΔNp63 transcriptionally regulates DGCR8, a component 
of microRNA processors (DGCR8/Drosha) to process from primary microRNA to 
precursor microRNA. When ΔNp63 transactivates DGCR8, its protein properly 
processes microRNA470 (miR470) and microRNA 145 (miR145). These two miRNAs 
repress Oct4, Sox2 and Nanog transcripts and cells can undergo proper differentiation.  
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